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ABSTRACT 
Chronic pain (CP) has a high prevalence worldwide. Yet, the mechanisms 
behind it are largely to be explained. One possible cause of CP is inflammation. The 
Dietary Inflammatory Index (DII) assesses the tendency of diet to cause inflammation.  
The association between DII and presence of chronic pain in neck and/or 
lower back was studied, as well as pain duration longer than 24 hours and longer than 3 
months. The hypothesis was that higher levels of DII are associated with increased pain 
presence and duration. A population of 3966 individual taken from the 2003-2004 
NHANES survey was considered. Baseline characteristics were analyzed with chi-square 
test and t-test. Univariate and multivariable analysis were performed using logistic 
regressions. Manual selection method was used for final model construction. The 
analyses performed were cross sectional. 
DII levels were deemed significantly associated with presence of pain in 
lower back and/or neck in the final model (p= 0.0346; Odds Ratio (OR)= 1.031; 95% 
Confidence Interval (CI)= 1.002 - 1.060) which included another four relevant covariates. 
DII levels were also deemed significant in association with pain longer than 24 hours 
(p=<.0001). Lastly, DII levels were significantly associated with pain lasting longer than 
3 months in the univariate analysis (p= 0.0164; OR=1.012 95%CI=1.042 - 1.124), 
although this association was lost in the multivariable analysis (p= 0.2956). From the 
results of this study, it appears that higher levels of DII (as a result of a pro-inflammatory 
diet) may play a role in the etiology mechanism of chronic pain and possibly in its 
perpetration. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
1.1.1 Chronic pain and inflammation 
Chronic pain is a common morbidity affecting approximately 20% of the 
adult population in Canada 
[1]
. Chronic pain has a high impact in terms of cost in 
Western countries
[2]
. In the United States, around 30% of the population have a 
chronic pain condition, bringing the total annual cost to 500–600 billion dollars [3, 4]. 
In Canada, a study by Phillips and Schopflocher reported the costs related to chronic 
pain to be higher than HIV, cancer and heart disease combined 
[5]
. This figure takes 
into account direct health care costs (more than $6 billion per year) and estimates of 
productivity loss including sick leaves ($37 billion per year). Moreover, a recent 
study on incremental costs in the province of Ontario found that the average cost of 
treating chronic pain patients is ~51% higher than patients without chronic pain 
[6]
. In 
countries of the European Union, literature in the area of chronic pain is scarce 
[7]
. 
According to a study by Tudler et al. the overall cost of low back pain (both acute and 
chronic) is 1.7% of the entire gross domestic product 
[8] 
in the Netherlands;
 
20% - 
30% of this figure is due to chronic low back pain alone. In general, most studies have 
been focusing on chronic low back pain, as it is the most prevalent chronic pain in the 
general population 
[9]
. 
The burden of chronic pain is not limited to quantifiable monetary 
expenses; disability and quality of life are negatively impacted as well. Chronic pain 
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has been described as a contributing factor for developing disability 
[10]
, and is 
considered one of the leading causes for disability worldwide 
[11]
. Moreover, longer 
durations of pain are correlated with worse disability outcomes 
[12]
. Disability has also 
been found to be a negative predicting factor for patients’ outcomes [13], and to 
particularly affect and reduce work productivity 
[14]
, and to negatively impact quality 
of life 
[15]
. The mechanisms behind these associations seem to be mediated by 
psychosocial factors 
[15]
 and work satisfaction 
[16]
. 
The causes and mechanisms behind chronic pain are still largely unclear 
[17]
; multiple factors are described in the literature as being involved in the origin and 
perpetration of chronic pain 
[18]
. These factors include some general, non-organic 
aspects (e.g., psychosocial factors 
[19]
) as well as various organic aspects (e.g. neuro-
modulated sensitization 
[20]
 and health status 
[15] 
among others). These factors are 
covered in detail in the literature review chapter. 
Of particular interest to this thesis is the literature finding of an 
association between inflammation and chronic pain. For example, chronic pain 
manifests clinically as different subtypes, including single site (or regional) chronic 
pain and multisite chronic pain 
[21]
, which present dramatic differences in prognosis. 
Multisite chronic pain is more likely to be associated with poorer functional outcomes 
[22]
, disability 
[23, 24]
 and risk of developing depressive and anxiety disorders 
[25]
. In 
2014, one study reported that these patients had higher levels of inflammatory 
markers and an increased immune response compared to single-site pain patients 
[21]
. 
Similar results were reported by another study in 2015, which showed a 
significant association between concentration of substance P (an important 
inflammatory marker) and level of pain in patients with a systemic inflammatory 
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disease (Rheumatoid Arthritis) whereas the association was not observed in patients 
with Osteoarthritis (a degenerative disease characterized by the absence of systemic 
inflammation) 
[26]
. Just like substance P, many other factors correlated with 
inflammation appear to be contributing to the origin or perpetuation of chronic pain in 
the human body (see literature review section of this manuscript). These findings 
suggest that patients with higher pain levels tended towards an overall higher 
inflammatory status 
[27]
, which highlights a possible relationship between the 
inflammatory status of the patient and the presence, quantity, and quality of pain. 
A variety of biomarkers that are involved in the inflammatory process 
have also been associated with specific diets; these pro-inflammatory diets seem to 
increase the human body’s inflammation level [28, 29]. Inflammatory biomarkers 
involved with diets are discussed in the literature review chapter of this thesis. Even 
though these findings suggest a possible link between diet, inflammation, and chronic 
pain, there is a literature gap on the interaction between diet and chronic pain. 
 
1.1.2 Dietary Inflammatory Index 
Specific diets have been found to have a different inflammatory impact on 
the body 
[28, 30-36]
. Each food has different properties regarding the inflammatory 
response elicited in the body 
[37], where quantity and frequency of each food’s 
consumption play an important role in the overall inflammatory effect 
[38-43]
. For this 
study, it was paramount to quantify the impact that a specific diet as a whole had on 
each individual involved. For this reason, the Dietary Inflammatory Index (DII) has 
been used to test the relationship between the presence of chronic pain and diet-
related inflammation level. 
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The DII is a widely used measure for assessing the inflammation level 
related to a specific diet; its latest and most updated version (2010), described by 
Shivappa et al. 
[44]
, was used for this study. The DII aims to quantify the amount of 
inflammation due to specific combinations of food intake. It was developed using 
worldwide data on diet and inflammation, and has been validated 
[30, 45]
. In the 
creation of the DII, each specific food was assigned a value according to its effect 
(pro- or anti- inflammatory) on the human body. This food-specific value was then 
factored in with quantity and frequency of consumption in an individual’s diet to 
calculate the final overall DII score. The dietary data was available at the CDC 
(Center for Disease Control), and it was part of the National Health And Nutrition 
Examination Survey (NHANES). The NHANES is an ongoing program of surveying 
the American population to assess health status and nutritional habits. Within this 
survey, the dietary data were collected using the Food Frequency Questionnaire 
(FFQ), a semi-quantitative questionnaire adapted for the US population.  The 
complete process on how the DII was developed, as well as how it is calculated, is 
described in chapter 3 of this manuscript. 
 
1.2 Rationale 
There is a high degree of controversy regarding the understanding of 
chronic pain’s underlying etiological mechanisms, treatment policies and protocols. 
When considering the prevalence, impact (both on society and individuals) and high 
amount of resources allocated to its treatment, clinical results are still far from 
satisfactory 
[46]
. 
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Chronic pain sufferers account for a significant portion of the patients 
seen in outpatients physiotherapy clinics (up to 20% of total population and up to 
80% of total revenue)
 [47]
. This statistic clearly points to the need of these patients to 
frequently and regularly visit outpatient clinics, which highlights the lack of long-
term results provided by physiotherapy treatment. Outside of physiotherapy settings, 
chronic pain is often managed by physicians with drugs 
[48]
, an approach that leads to 
other serious side effects 
[49, 50]
, and in most cases, fails to provide a valid long-term 
solution 
[51]
.  
Chronic pain in the neck and in the lower back were chosen for this study 
due to their relevance for the general population 
[52]
, since they are a most common 
source of disability 
[53, 54]
 and their high prevalence is expected to increase in the next 
few decades 
[9]
. 
A major issue for a clinical approach to chronic pain is that the etiology 
behind chronicity is still largely unclear. Overall, chronic pain has been associated 
with multiple factors 
[55] 
(which are all described in the literature review chapter
 
of 
this thesis) and should be approached accordingly 
[56]
. No relevant research on the 
association between diet-related inflammation and chronic pain could be found in 
literature. The present study contributes to the further understanding of the 
mechanisms linked to chronic pain. 
Since inflammation impacts the experience of pain, diet-related chronic 
inflammation may also affect the overall experience of pain (presence, severity, 
number of pain sites, and duration). The underlying mechanism could be that specific 
dietary patterns elevate, even slightly, the level of systemic inflammation in the body, 
counteracting or hindering the body’s attempt to recover from acute pain. Therefore, 
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people with certain dietary patterns defined as pro-inflammatory would be more prone 
to increased, persistent, or chronic pain; their bodies are less able to recover from a 
painful state due to the heightened systemic inflammation 
[57]
. 
Current evidence indirectly supports the association between DII scores 
and chronic pain by describing possible mediating pathways. For example, higher DII 
scores have been associated with higher levels of inflammatory markers, such as C-
Reactive Protein (CRP) 
[30]
, substance P 
[58]
, interleukin 6 (IL-6) 
[34]
, and 
homocysteine levels 
[59]
. Different studies show that heightened levels of these 
markers are associated with higher incidence of certain inflammation-based 
conditions, such as colorectal cancer 
[60]
, asthma and decreased lung function 
[34]
, 
obesity 
[61]
, prostate cancer 
[59]
, lower bone mineral density 
[32]
 , and, most importantly 
for this study, chronic pain 
[58]
.  
Another possible mediating mechanism between diet and inflammation 
can involve the gut microbiota. It has been shown that dietary patterns influence the 
state of inflammation of the intestines by affecting the gut microbiota 
[62, 63]
 and by 
creating a local immune inflammatory-type response 
[64, 65]
. This local inflammatory-
type response can become chronic and systemic 
[66]
 and cause a multi-systemic 
sensitizing effect, which in turn can cause acute pain to become chronic. Another 
possible mechanism involving the gut microbiota involves the reciprocal modulation 
of the brain and the gut microbiota; this modulation is mediated by different signaling 
mechanisms (both neurotransmitters and endocrine hormones), and has been linked to 
the pathophysiology of a wide array of conditions involving the human brain, 
including chronic pain 
[67]
. More research is needed in this area. 
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1.3 Purpose of this study 
The goal of this study is to investigate the association between diet-related 
inflammation measured with the DII and chronic pain. This was achieved by 
analyzing the 2003-2004 US National Health and Nutritional Examination Survey 
(NHANES) data 
[68]
.  
A secondary objective was to determine if individuals with higher DII are 
more likely to experience pain for a period of time greater than 24 hours. This 
objective addresses the time-dependent aspect in the determination of pain as chronic 
(pain lasting more than 3 months). For the complete definition of chronic pain refer to 
the review section of this manuscript. In 2006, the CDC used this cut-point (people 
who experience pain for a period >24hrs) in an assessment of the general population 
of the US affected by chronic pain 
[69]
. This was later found to provide a conservative 
estimate 
[70]
 in the chronic pain assessment and was therefore considered relevant for 
a good estimation of chronic pain prevalence in the US population 
[71]
. 
A tertiary objective was to study the length that patients that had pain for, 
among those who responded positively on having pain for longer than 24 hours in the 
previous month. This variable has been assessed as a dichotomous variable using a 
cut-off point of three months. The objective was therefore to assess if higher levels of 
DII were associated with pain experienced for longer than 3 months. As mentioned 
earlier in this chapter, this timeline has been used to define chronic pain in literature 
and clinical practice.  
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1.4 Organization of this study 
This thesis consists of five chapters. Chapter 1 is a general introduction to the 
study. Chapter 2 covers the relevant literature review regarding chronic pain, 
inflammation (with a particular focus on diet-related inflammation), and the DII. 
Chapter 3 focuses on the methods utilized for this research, including information on 
data collection, study sample (inclusion and exclusion criteria), calculation of the DII, 
treatment of relevant covariates and statistical methods used. Chapter 4 presents an 
analysis of the results obtained from the methods described in chapter 3. Chapter 5 
offers a discussion of the significance and limitations of the results, highlighting the 
conclusions that can be drawn from this analysis. An appendix section can be found at 
the end of this manuscript with the relevant parts of the questionnaire used to collect 
the data used in this study. 
Due to the manuscript format utilized in this thesis, some repetitions can be 
found throughout. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Epidemiology of chronic pain  
The International Association for the Study of Pain (IASP) defines 
chronic pain (CP) as pain that persists beyond the average healing time for the 
involved tissues 
[72]
. The usual timeframe that is pragmatically accepted and used is a 
period of 12 weeks (or 3 months) after which acute pain is defined as chronic. 
When analyzing CP prevalence, some authors estimate that approximately 
19% of the adult population in Canada is affected 
[73]
, suggesting that  CP is more 
prevalent than diabetes 
[74]
 or asthma 
[75]
. In the US, the prevalence ranges between 
20% 
[76]
 and 30% 
[77] 
, while in Europe it was found to be around 20% 
[78]
. Part of the 
issue with CP is that, in spite of the condition’s high prevalence, only 2% of people 
affected by CP will seek help at a specialized clinic 
[78]
. The other 98% will manage 
their condition  through their primary physician, mainly by pharmacological 
intervention 
[79]
, despite evidence that the pharmacological intervention still lacks in 
providing significant, reliable, and consistent improvement 
[80]
. 
The financial burden of CP is considerable, adding up to over CAD43 
billion/year in Canada 
[81]
, €200 billion/year in Europe, and $635 billion/year in the 
USA (based on 2008 data)
[3]
.
 
This burden comes from both losses in productivity and 
active treatment costs. When taking into account the high impact that CP has on both 
the affected individuals and on the entire society, the understanding of the underlying 
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etiological mechanisms, treatment policies and protocols, as well as clinical results 
are still far from satisfactory 
[46]
. 
 
CP is a complex condition that involves many factors, including both 
organic and non-organic aspects. Non-organic aspects involve multiple dimensions 
intertwined into the large umbrella known as psychosocial factors, while examples of 
organic factors include acute uncontrolled pain, age, gender, physical deconditioning 
and genetic factors. From a general perspective, more research is needed to further 
understand CP and its mechanisms. 
 
2.1.1 Non-organic contributing factors. 
Psychosocial factors (PSFs) are a broad variety of factors that have been 
associated with the overall experience of CP 
[19, 82, 83]
. Even though the mechanisms 
behind this association are still unclear 
[84]
, its existence and relevance is known and 
commonly accepted in pain medicine 
[19, 82]
. The various factors involved in the 
psychological process of chronic pain are interconnected and should always be 
considered as part of a whole, unique process. PSFs that impact CP can be 
categorized into two distinct classes for analysis purpose: psychological aspects 
(treated in section 2.1.1.1) and social aspects (discussed in the section 2.1.1.2). 
 
2.1.1.1 Psychological Factors. 
From a general standpoint, psychosocial factors have been associated with 
many conditions 
[85]
 (e.g. heart disease 
[86]
), as well as with the general health 
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condition of individuals 
[87]
. Factors like depression, catastrophizing, uncontrolled 
stress and hostility have been widely described in literature as having an overall 
impact not only on individuals but also on public health 
[87]
.  
A variety of PSFs have also been associated with CP, with the relevant 
ones listed below. 
 
2.1.1.1.1 Attention. 
The ability to direct and focus one’s attention has a strong connection 
with pain 
[88, 89]
. On one hand, it is a key functional goal of pain to heighten the 
attention level and to direct this attention towards protecting from a threat, which is 
usually a possible cause of injury for the human body 
[90]
. This understanding helps 
explain why it is difficult to ignore pain, even when present under conditions that are 
not necessarily of immediate threat, like chronic pain. On the other hand, attention is a 
component of the pain experience, since hypervigilance (excessive attention towards 
pain) has been associated with presence of chronic pain 
[91]
. 
Some studies suggest that attention becomes impaired in patients with 
chronic pain, and the inclusion of attention training exercises in those patients’ 
treatment may improve the clinical outcome 
[92, 93]
. These findings point out a 
possibility of a reciprocal interconnection between pain and attention: pain appears to 
impair one’s ability to focus the attention to perform meaningful tasks, yet attention 
seems to be needed in order to break the pattern of chronicity. 
[94] 
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2.1.1.1.2 Interpretation of noxious stimulus. 
A noxious stimulus is a sensory response to a potential or actual damage 
to body tissues 
[95]
. It may cause pain, but the link may involve other factors as well 
[96]
; pain is not always elicited at the occurrence of a noxious stimulus. 
Interpretation of the noxious stimulus includes a range of different factors 
that are deeply interconnected with the emotional status of the individual 
[97]
. The 
interpretation depends upon previous experiences that the patient had, which impacts 
how the patient’s brain processes current experiences. A good example for this 
mechanism is allodynia, defined as a noxious stimulus that would not normally be 
experienced as painful.  
Emotions seem to play an important role in the processing of pain in some 
predisposed patients 
[98]
. Patients with different personal stories (e.g., previous 
trauma) and interpretation patterns (e.g., anxiety 
[99, 100]
) may process the experience 
of pain in completely different ways. Thus, the interpretation of pain is dependent on 
beliefs and attitudes 
[101, 102]
, expectations
 [101, 103]
, cognitive sets 
[84] 
(e.g., pain 
catastrophizing 
[104]
), emotion regulation 
[105] 
(e.g., depression 
[100]
) and coping 
strategies 
[97]
. 
 
2.1.1.1.3 Pain Behaviors 
Certain behavioral approaches to pain have been shown to negatively 
affect the overcoming of chronic pain patterns 
[106]
. In the literature, there are three 
main behavioral models highlighted that negatively affect chronic pain: fear-
avoidance, misdirected problem-solving and diathesis-stress.  
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The fear-avoidance model provides a possible explanation on how acute 
pain transitions to chronic. This model is based on the idea that the fear of pain or re-
injury can cause an increase in disability to a greater extent than the pain itself. The 
increase in disability is due to decrease in activity participation which is justified by 
fear of re-injury or further damaging 
[107]
. The reduced amount of activity 
participation creates a spiraling pattern where the individual becomes progressively 
less engaged in activities of daily living, which then results in physical deconditioning 
or emotional withdrawal due to social implications. Both of these scenarios can 
contribute to the increase in sensitivity to pain 
[107, 108]
. 
The misdirected problem-solving model is based on an inappropriate 
application of the otherwise useful problem-solving approach that is characteristic of 
the human species 
[109]
. In the case of chronic pain, the tendency to focus on problems 
in order to solve them results in a hypervigilant status, which fragments attention, 
fueling worries and fears and creating a perseverance loop (“vicious cycle”) that 
prevents patients from resolving pain 
[110]
. 
The diathesis-stress model is based on the idea that a baseline amount of 
stress in an individual who experiences pain would reduce the ability of such an 
individual to deal with the recovery process, thus predisposing them to chronic pain 
[111]
. This model puts a great importance on the role of emotional processing and 
highlights the higher risk that emotional distress yields in regards to CP 
[112]
. 
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2.1.1.2 Social factors 
The “social” component of PSFs includes all sociodemographic aspects 
that have been linked to CP; the common denominator of these aspects can be 
summarized by the word deprivation.  
Deprivation in certain social aspects seems to be associated with the 
presence of chronic pain. There are three main areas of deprivation that are related to 
the presence of chronic pain: low household income 
[113]
, belonging to deprived socio-
demographic groups 
[114]
 and a lower level of education 
[114, 115]
. In relation to these 
areas, employment status plays a key role as well 
[116]
. 
Social factors are therefore relevant, and yet they could be better 
addressed through politics rather than in clinician’s practice, as some authors suggest 
[114, 117]
. It is nonetheless important to acknowledge the presence of these factors and 
keep them into account when studying CP. 
 
2.1.2 Organic contributing factors. 
There are many organic factors that play a role in patients’ chronic pain 
experiences. For analysis purposes these factors can be divided into two categories: 
organic factors that cannot be modified (section 2.1.2.1) and those that can (section 
2.1.2.2). 
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2.1.2.1 Non-modifiable factors. 
2.1.2.1.1 Sex 
Recent studies suggest very strong evidence on the higher prevalence of 
chronic pain in females 
[118-121]
, even though the reason behind it is not clear 
[118, 119]
.  
Women show higher prevalence of a variety of different chronic 
conditions including chronic pain 
[122]
. The majority of these conditions are currently 
considered to be mediated by an heightened inflammatory state 
[122]
. One study points 
out that the inflammatory process could be involved 
[123]
. This higher prevalence 
could be mediated by organic, structural differences in specific inflammatory 
pathways which may favor inflammation 
[123]
 and pain sensitivity in women 
[122]
.  
In contrast a few other studies point out (although with a weak evidence 
level) that part of the mechanism for chronic pain in women could be mediated by the 
hormonal menstruation cycle 
[124]
. These hormones have an anti-inflammatory effect 
[125]
, which appears contradictory to the above-mentioned inflammatory-based theory. 
A survey of the current literature shows that there is not enough evidence 
to support either theory. Nevertheless, it is important to recognize the difference 
between sex and take it into account when analyzing data involving pain. 
 
2.1.2.1.2 Age 
An association between age and CP has been shown, yet there is still 
uncertainty on the effect of aging in older people, as it relates to CP. While all studies 
show a linear positive association between CP and increasing age up to the age of 65, 
there are differences when it comes to older age. Some studies show that the 
prevalence of CP in older populations keeps increasing, virtually following the linear 
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progression evidenced in younger people and middle age 
[126]
. Other studies found 
that the overall prevalence of CP decreases in older populations, creating the peak of 
CP prevalence in the age group between 45 and 65 
[127]
. 
The reason for these different findings is not clear, as it could have 
different reasons. It could be either a mere survival effect (people without CP have 
longer life expectancy), or an artifact (older people not reporting CP because they 
consider it non-relevant or normal for their age), or it could have in fact a protective 
effect.  
2.1.2.1.3 Genetics 
Genetics play a role in the incidence of CP 
[128, 129]
, though evidence is not 
strong, mostly due to the limited number of studies in the area. All of the studies 
available seem to point in the same direction: a complex picture of chronic pain 
conditions (including fibromyalgia 
[130]
) is mediated by minor contributions from a 
high number of polymorphisms involving single nucleotides (single base mutations). 
Each of these nucleotide is involved with a different functional pathway, and each has 
a different impact on the condition mechanisms 
[128, 131, 132]
.  
While the genetics of an individual clearly cannot be changed or 
addressed directly, the expression of genes within the human body can be influenced 
through a process known as DNA methylation. This process, being a modifiable 
factor involved in CP, is described later in the current chapter. 
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2.1.2.1.4 History of trauma, injury, interpersonal violence 
Two large studies 
[133, 134]
 found that a self-reported history of violence or 
abuse perpetrated either at home or in a public place was  associated with an increased 
risk of  having CP later in life. The reasons behind this have not been established yet. 
 
2.1.2.2 Modifiable factors (non-pharmacological) 
2.1.2.2.1 Presence of pain 
Presence of acute, uncontrolled pain 
[135]
 and presence of chronic pain in 
another body site 
[136]
 are strong predictors of CP. This association follows a positive 
linear trend: higher pain scores, longer durations of experiencing pain, and more 
places involved with pain in the body are all associated with higher chances of 
developing CP 
[137, 138]
. This emphasizes that health care professionals have to 
recognize, acknowledge and address any reported pain from the patient in a timely 
manner. Failing to do so could put the patient at higher risk of developing CP. 
CP affects the brain through the remodeling process of neuroplasticity 
[139]
; changes in the brain happen very early on in painful stages (as early as 8 days) 
[140]
, and early intervention can help address the problem before the changes become 
chronic and harder to address 
[141]
. 
 
2.1.2.2.2 General Health 
2.1.2.2.2.1 Co-morbidities 
The prevalence of CP is higher in individuals who are affected by other 
chronic conditions when compared to people who are not 
[142]
. There is evidence in 
the literature for a number of these conditions, including heart diseases and 
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respiratory diseases 
[143]
. The reason is not clear, but it may be a consequence of the 
disabilities associated with these conditions 
[144]
. Additionally, it may be caused by an 
increase in pain sensitivity in the periphery, which can then trigger chronic pain-like 
neuro-patho-physiological adaptation, both in the central and the peripheral nervous 
system 
[145]
.  
 
2.1.2.2.2.2 Sleep 
A number of studies point out that sleep disturbances are a predisposing 
factor for chronic pain. These results highlight the role of sleep quality as a predictor 
of pain onset and persistence 
[146]
 as well as pain intensity 
[147]
.  
The mediating mechanisms for this causal relationship are still to be 
elucidated 
[148]
. 
2.1.2.2.2.3 Obesity 
Obesity has been associated with chronic pain 
[149]
. The causal 
relationship may be mediated, at least in part, by the increased weight bearing demand 
often paired with poor physical activity 
[150]
. This combination has been pointed out to 
negatively affect joint and soft tissue extensibility 
[151]
.  
As different studies suggest, there are other factors linking CP and 
obesity: familiarity and environmental factors have been found to play a major role 
[152-154]
. Overall obesity needs to be taken into account when studying and treating CP 
(at least as a secondary or tertiary intervention).  
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2.1.2.2.2.4 Physical activity 
There is limited evidence that physical activity benefits CP. Likely, the 
lack of research with broader generalizability regarding chronic pain conditions and 
populations is the main reason for this limitation 
[144]
. A few studies which used 
different protocols of Yoga, Pilates and Tai-Chi obtained modest results and their 
generalizability is very limited 
[155]
. Thus, the most effective exercise protocols that 
could be found in literature have been those specific to each patient’s situation, rather 
than a generalized protocol for all CP patients 
[156]
.  
More research is needed in this area to clarify which clinical sub-groups 
of patients would benefit the most from specific types of interventions. 
 
2.1.2.2.2.5 Alcohol consumption 
Alcohol has an analgesic effect that is limited in time, and yet it is still 
widely used as a self-medication 
[157]
. The major issue with alcohol use as an 
analgesic is that, paired with limited efficacy, it also creates tolerance, which may 
lead to alcohol abuse. Withdrawal from alcohol generally increases pain sensitivity, 
which makes the withdrawing process harder and can lead back to alcohol or other 
substances abuse in order to cope with the increased pain 
[158]
.  
A recent study pointed out that CP patients are less likely to turn to 
alcohol, when compared to the general population 
[159]
. 
 
2.1.2.2.2.6 Smoking 
Current literature shows evidence of an association between smoking and 
both increased pain as well as a higher number of pain sites 
[160-162]
. Some authors 
 20 
suggest that the negative effects that smoking has on the human body yields a 
negative impact on CP as well 
[163]
, however no causal relationship has been 
demonstrated.  
Another aspect of the relationship between smoking and CP that is yet to 
be clarified is whether smoking cessation has a positive effect in reducing CP. The 
compounded fact that smoking cessation is usually lower in CP patient makes this 
study even harder to be completed 
[164]
. 
 
2.1.3 Neurological modulation of CP 
There are multiple neurophysiological changes that occur in the human 
body when acute pain transitions to chronic. The causes and mechanisms behind the 
process are not entirely clear, but according to current understanding, there are at least 
two neurological processes involved, sensitization and modulation, each of which is 
then divided into two parts. These processes happen simultaneously, influencing each 
other along the transition between acute to chronic pain. 
 
2.1.3.1 Sensitization 
2.1.3.1.1 Peripheral 
Peripheral nociceptors respond to noxious stimuli when the critical 
intensity threshold is reached. As a consequence, conduction, transduction and pain 
threshold of the afferent fibers are enhanced, facilitating the likelihood of spontaneous 
firing 
[165]
. 
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Following this initial stage, the peripheral nervous system goes through a 
phase of inflammation (known as neurogenic inflammation), where a cascade of 
inflammatory markers is initiated in the involved nerve area. Physiological 
consequences of the neurogenic inflammation are an increase in the number of 
channels and receptors on the cell membrane, an increase in ion channels permeability 
and the expression of genes facilitating pain transmission 
[166]
. 
The combination of these events contributing to the local peripheral 
nerves excitability is known as “peripheral sensitization”. This stage typically lasts a 
few days to a few weeks depending on the severity of the initial stimulus, though in 
some individuals the recovery process from a state of nociceptive alertness does not 
resolve. The reasons behind this failure to recover are not clear, but recent studies 
point out the possible involvement of factors including systemic 
immune/inflammatory heightened response 
[167]
, genetic factors 
[131, 132]
, and 
environmental involvements 
[168]
. 
 
2.1.3.1.2 Central 
A prolonged state of peripheral excitability may lead to an “overflow” of 
excitability in the central afferent structures of the nervous system, from the spinal 
dorsal horns to the centers for pain in the brain 
[169]
.  
Specific areas of the brain have been found to have an activity level 
altered by pain presence: the primary somatosensory cortex (S1), the secondary 
somatosensory cortex (S2), the prefrontal cortex (PFC), the anterior cingulate cortex 
(ACC), the cerebellum, the thalamus, the amygdala, the insula, and the mesolimbic 
reward circuit 
[170-172]
. These areas are not solely dedicated to processing the 
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experience of pain, which again highlights how multi-layered the processing of that 
experience is for humans 
[173]
. 
A variety of chemokines, cytokines, and neuropeptides are involved in 
this multi-faceted process that constitutes the pathophysiological state of central 
sensitization 
[174]
. In this state, the amount of stimuli necessary to reach the threshold 
for pain becomes significantly reduced. The neurophysiological process involved in 
central sensitization as a consequence of enhanced central activation of nociceptive 
pathways is mediated by a group of mechanisms known as N-methyl-D-aspartate 
(NMDA)-dependent mechanisms 
[175]
. An example of chronic pain condition where 
the NMDA-dependent mechanism plays a key role is the phantom limb pain 
[176, 177]
. 
 
2.1.3.2 Modulation 
2.1.3.2.1 Descending 
Descending modulation has been found to contribute to the top-down 
process of transmission and regulation of pain from the cortical and limbic areas in 
the brain to the dorsal horns of the spine. Research on how structures and functions 
are altered in the event of CP is still lacking 
[178]
, but there are a few aspects that have 
supporting evidence in literature. 
The periaqueductal grey (PAG) in the midbrain and the rostral 
ventromedial medulla (RVM) have been proven to be involved in the descending 
modulation system 
[20, 178, 179]
. These two centers contain a high number of opioid 
receptors and endogenous opioids. Descending pathways are connected with the 
dorsal horns, where they project neuro-signals which modulate pain transmission. 
These pathways utilize noradrenaline and serotonin as neurotransmitters. 
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The descending pathways use two modulatory mechanisms: inhibitory 
and stimulatory. Both mechanisms need to be involved and balanced for the 
experience of pain to be healthy and functional 
[20]
 (that is, noxious experience 
proportionate to the stimulus). It appears that an imbalance between these two 
systems is one contributing factor that triggers acute pain to become chronic 
[170]
. 
Both of these functions appear to be regulated by the PAG; located in the brainstem, 
the PAG projects to the rostroventral medulla and the spinal horns. The anatomical 
position of such a important modulatory component of the brain puts into evidence 
that the whole CNS is involved in the modulation of pain and possibly in the 
mechanisms behind chronicity. These findings point to a new area of research to be 
performed. 
A 2014 study 
[180]
 provides evidence on how brain areas connected to the 
PAG change in patients affected by chronic low back pain. The results of this study 
highlight neuroplasticity as part of the development of chronic pain, in particular as a 
mechanism necessary for the body to adapt to the pain. 
 
2.1.3.2.2 Ascending  
Ascending modulatory pathways are deeply interconnected with 
descending pathways in the regulation of nociception. The regulatory mechanisms in 
this case are based on positive and negative feedback loops. 
The best example of this mechanism is the renowned “Gate Control 
Theory”. This theory explains how the activation of non-nociceptive neurons may 
interfere with the transmission of nociceptive stimulus that was simultaneously 
evoked in the same spinal tract area, by the activation of specific modulatory and 
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inhibitory cells in the spine. The same theory also illustrates the modulatory process 
involving the descending pathways. Certain neural tracts bypass the spinal 
modulatory and inhibitory “gate” reaching the brain directly, and activating the 
descending modulatory pathways that further contributes in the modulation of pain.  
The complexity of these mechanisms has not been sufficiently studied and 
it is not fully understood. 
 
2.1.4 Inflammation 
2.1.4.1 Introduction 
Inflammation and sub-inflammation have been increasingly pointed as 
possible underlying causes for a large number of chronic conditions. Since chronic 
diseases account for the largest portion of pathologies affecting wealthier societies (as 
high as 70%) 
[181]
, there is increasing attention from the scientific community to 
studying the relationship between inflammation and chronic conditions, as well as 
their possible causes and association. Particularly, one aspect of chronicity that has 
been extensively researched is the link between chronic sub-inflammation (measured 
by heightened blood levels of C-Reactive Protein, a widely used inflammatory 
marker) and the incidence of cardiovascular diseases (CVD) 
[182-185]
. More 
specifically, there is evidence that higher C-Reactive Protein (CRP) levels are related 
to increased incidence of coronary heart disease (CHD) 
[186]
. Other markers (e.g. 
interleukin 6 (IL-6) levels 
[34]
 and homocysteine levels 
[59]
) have been studied as well, 
and there is evidence for their contribution to atherosclerosis and CVD. These 
markers have all been described in the review authored by Stoner et al. 
[187]
.  
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The demonstrated association 
[188]
 between inflammation and CVD is only 
one of many examples on how inflammation  is connected to chronic conditions. 
Other diseases associated with chronic inflammation include: osteoarthritis 
[189]
, 
metabolic syndrome and insulin resistance 
[39]
, cirrhosis 
[26]
, asthma 
[34]
, rheumatoid 
arthritis 
[190]
, different cancers 
[31, 32, 59, 191, 192]
 and even depression 
[193]
. The 
associations are so vast in number that various authors have hypothesized that western 
lifestyle itself (with a pool of different contributing factors including diet, stress, 
pollution and lack of daily physical activity) could be the leading cause of chronic 
conditions 
[194]
.  
Even though inflammation and sub-inflammation have been found to be 
very important as a pathologic cause to many chronic conditions, a scarce amount of 
literature could be found on the direct link between inflammation and chronic pain. 
 
2.1.4.2 Inflammation and chronic pain 
Of vital importance for this study is the link between inflammation or sub-
inflammation and sensitivity to pain as well as the number of sites where the pain is 
located. Afari et al. 
[195]
 found that higher levels of CRP are associated with an 
increased pain sensitivity (both in regards to threshold levels and tolerance). 
Additionally, Lee et al. 
[196]
 found that CRP levels are inversely related to pain 
threshold at the wrist, which means that higher CRP levels (and therefore higher 
inflammation levels) meant it was easier for the study subjects to experience pain.  
Generaal et al. 
[21]
 found that markers for basal inflammation were higher 
in patients with chronic multisite pain when compared to controls, although the 
statistical significance was lost after adjustment for different covariates. In that study 
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[21]
, the multisite pain group versus the controls was defined as three sites  or more. 
This arbitrary cut-off might have decreased the significance of the systemic effect that 
basal inflammation has as a possible underlying cause for multiple pain sites. The 
presence of two pain sites might indicate that a systemic process is already underway 
[197]
.  
Another study by Li et al. 
[198]
 provides a good explanation on the role of 
neuroinflammatory patterns as contributors to chronic pain, and also as a possible 
route for treating such pain. In another very recent study, Lasselin et al. 
[27]
 point out 
that low-grade inflammation may have an adverse effect on the outcome of behavioral 
treatment used for treating chronic pain in adults.  
In a 2015 study 
[58]
, substance P serum concentration was found to be 
positively correlated with chronic pain intensity levels when analyzing individuals 
affected by rheumatoid arthritis (RA, a systemic auto-immune inflammatory-mediated 
condition causing joint pain) and individuals affected by osteoarthritis (OA, a 
degenerative condition which causes joint pain, mediated by local inflammation). 
Substance P concentration was elevated in both groups, although significantly 
different between the two groups, and higher in the RA group. This finding stresses 
the important role of the inflammation process in both of these painful conditions, and 
also highlights a connection between autoimmune diseases, systemic chronic 
inflammation, and pain levels. Overall, this study points out that inflammation level is 
associated with chronic pain levels. 
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2.2 Diet and inflammation 
2.2.1 Diet-related effects on human body 
The focus of this research was to study the effects of diet on the human 
body in a context to better understand the impact of inflammation on human health. A 
particular emphasis has been placed on inflammation, diet, chronic pain, and how 
these factors interact with each other. These interactions have been researched in the 
literature and reviewed. 
Research on dietary-mediated physiological responses has shown relevant 
associations with a broad spectrum of chronic conditions, mediated by a variety of 
different mechanisms 
[199]
. These physiological responses include inflammatory and 
sub-inflammatory states 
[39, 41]
, oxidative state 
[200, 201]
, immune response 
[202, 203]
, DNA 
methylation level 
[35, 42]
, insulin resistance 
[38, 204]
, and blood fat levels 
[205, 206]
. A 
complete list of all dietary-mediated physiological markers associated with these 
responses and found in literature is listed in Figure 1. 
From the literature review of the above-mentioned physiological 
responses, sub-inflammatory states 
[27, 207]
, oxidative state 
[208, 209]
, immune response 
[207, 210]
, and DNA methylation level 
[211, 212]
 were found to be associated with CP. 
These associations are discussed later in this chapter (section 2.3). A mediating link 
between these associations and diet could not be found in current literature (note 1).  
Studies on the association between chronic pain and either higher blood 
fat levels or insulin resistance were not found in literature. Nonetheless, both higher 
blood fat levels and insulin resistance are associated with other chronic conditions, 
such as chronic migraine 
[213]
 and central obesity 
[214]
. Research on insulin resistance 
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and blood fat levels in association with CP could not be found in current literature as 
well.  
Figure 1: Inflammatory markers related to diet. 
Inflammation markers related to diet: 
Advanced glycation end products (AGEs) 
Angiotensin II (ANG II) 
E-selectin 
Heat shock protein (HSPs) 
Matrix metalloproteinases (MMPs) 
Myeloperoxidase (MPO) 
Platelet endothelial cell adhesion molecule1 (PECAM-1) 
Intracellular cell-adhesion molecule-1 (ICAM-1) 
Vascular cell adhesion molecule-1 (VCAM-1) 
  
Oxidative stress biomarkers related to diet: 
Isoprostanes 
Lipoprotein-associated phospholipase A2 (Lp-PLA2) 
Nitrotyrosine 
Oxidized LDL (oxLDL) 
 
Cytokines related to diet: 
CD40/CD40L 
C-reactive protein (CRP) 
Interferon-gamma (IFN-γ) 
Interleukin-1 (IL-1) 
Interleukin (IL-6) 
Tumor necrosis factor-α (TNF-α) 
 
Chemokines related to diet: 
Interlukin-8 (IL-8) 
Monocyte chemoattractant-1 (MCP-
1) 
Migration inhibitory factor (MIF) 
 
 
2.2.2 Dietary pattern and inflammation 
The associations between diet and inflammation have been increasingly 
pointed out in recent literature 
[28]
. From the review performed for this study, two 
main tools were found for evaluating the diet-related inflammation level in 
individuals. The first tool is known as the Dietary Pattern (DP) and the second one is 
the Dietary Inflammatory Index (DII). In this section of this study, DP literature 
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findings relevant to the interaction between diet and inflammation were evaluated. 
Section 2.2.3 is dedicated to the findings on diet-related inflammation as related to the 
DII. 
The Dietary Pattern approach takes into account the overall effects from 
each specific combination of nutrients and foods that are part of one’s individual diet. 
This is in opposition to other studies that focus on a limited number of specific 
nutrients or foods consumed. For the purpose of understanding the overall effect of 
diet, the Dietary Pattern approach offers a valid and thorough approach 
[215]
. 
Specific DPs have been associated with higher inflammation levels in the 
body and have shown interesting connections with chronic conditions, which make 
them relevant to understand how diet-related inflammation affects the human body. 
DPs that have been consistently associated with higher levels of inflammatory 
markers share some aspects. For example, Western DP 
[39, 40]
, meat DP 
[36]
, sugar DP 
[36]
, southern cone (of Latin America) DP 
[43]
 and bar DP 
[216]
 are all characterized by 
higher meat consumption, decreased vegetables and fruits consumption, as well as 
higher consumption of refined sugars and grains.  
An anti-inflammatory DP has been consistently found in the above 
mentioned studies and is usually called “prudent” [217, 218]. It is characterized by a 
higher consumption of vegetables, fruits, and whole grains along with a reduced 
intake of processed meat, refined sugars, and white wheat flour. Another DP, known 
as “Mediterranean”, shares similar food consumptions with the “prudent” one. These 
findings help illuminate what pro-inflammatory or anti-inflammatory diets look like.  
Chronic conditions were found to be associated with pro-inflammatory 
dietary patterns include type 2 diabetes 
[219-221]
, cognitive decline 
[222]
, decreased 
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endothelial function 
[223]
, higher risk of depression 
[224]
, and metabolic syndrome 
[220]
. 
No study could be found on the association between DP and CP. 
 
2.2.3 DII and inflammation 
The DII has been used for the diet-related analysis in this manuscript. The 
DII has been developed using a comprehensive review on inflammation and diet, and 
since its development, a wide body of literature has been produced using this tool. For 
these reasons it has been chosen for this work. 
 
2.2.3.1 DII construction 
The DII is a relatively recent (2014) and validated tool 
[37]
 for analyzing 
the level of inflammation that specific foods and nutrients contribute. These food and 
nutrients have been selected from an extensive review of 1943 articles, which resulted 
in 11 food consumption datasets that apply to 11 different areas and populations 
around the world. The analysis that led to these results looked at the association 
between six inflammatory biomarkers (IL-1β, IL-4, IL-6, IL-10, TNFα and CRP) and 
45 specific food items.  
For each of the 45 foods, a specific value of +1, -1, and 0 was given (pro-
inflammatory, anti-inflammatory, and null respectively). This value was then 
weighted according to the number of articles found and their design (better quality 
designs yielding more weight). An overall calculation was then made for each food, 
subtracting the anti-inflammatory values from the pro-inflammatory values to obtain a 
single, overall score for each food. Examples of these food components are different 
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vitamins (A, B6, B12, C, D, E), minerals (Fe, Mg, Se, Zn), macronutrients (protein, 
fats, carbohydrates), and spices (saffron, thyme, pepper, turmeric). 
The 24 hours’ food frequency questionnaire helped collect data on 
quantity and frequency of these foods.  The calculation of the DII was then made 
based on quantity and frequency of consumption for each of the 45 specific food item 
values found in the review, although frequently the foods identified in questionnaires 
yield data only on 25-30 food items. The final DII score for each person represents 
the sum of the identified items’ values calculated relative to the global diet dataset. 
This final score represents the overall tendency of one's diet to be pro-inflammatory 
or anti-inflammatory. 
A more technical description of the calculation process for the DII is 
presented in the following chapter. 
 
2.2.3.2 DII known effects 
The DII has been utilized increasingly since its creation in 2014. From a 
literature search, 58 articles with “Dietary Inflammatory Index” in the title are 
present. 
DII scores representative of pro-inflammatory diets have been associated 
with a variety of physiological changes and conditions. Among the physiological 
changes associated with a pro-inflammatory DII score are higher levels of a variety of 
inflammatory markers 
[225]
 (CPR 
[44, 226]
, TNF-α, IL-1, IL-2, IFN-γ and VCAM [227], 
and  IL-6 
[34]
), shorter telomere length 
[226, 228]
, decreased bone mineral density 
[229]
,  
and decreased lung function (assessed with FEV1) 
[34]
. 
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Regarding conditions associated with pro-inflammatory scores of DII, 
current literature suggests a negative association with insulin resistance, fasting 
glucose and post load glucose 
[230, 231]
, a heightened risk of asthma 
[34]
, a lengthier 
hospitalization time for surgically-treated colorectal cancer patients 
[232]
, presence of 
metabolic syndrome 
[225, 233-235]
, higher risk of developing certain cancers (colorectal 
[32, 60, 192, 236]
, prostatic 
[59]
, pancreatic 
[31]
, ovarian 
[237, 238]
, breast 
[239]
, gastric 
[240]
, 
bladder 
[241]
, and lung 
[242]
), higher indices of obesity 
[61]
, higher incidence of 
cardiovascular diseases 
[228, 234, 243-247]
, depression 
[245, 248]
, increased all-cause 
mortality 
[234, 246]
, decreased long term cognitive function 
[249]
, and increased risk of 
developing Multiple Sclerosis 
[250]
. Current research on the association between DII 
and chronic pain could not be found in the literature. 
 
2.3 Other possible mediating mechanisms 
between CP and diet 
Inflammation is not the only possible mediating cause between CP and 
diet. At least four other possible mechanisms have been identified in the literature. 
Those mechanisms are described in the following sections. 
Blood fat levels and insulin resistance have yet to be specifically 
researched as possible contributing factors to chronic pain, but both are associated 
with other chronic conditions, such as chronic migraine 
[213]
 and central obesity 
[214]
. 
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2.3.1 Immune response, diet, and chronic pain. 
Generaal’s study [21] pointed out that an increased response from the 
immune system might be further studied as a “potential biomarker for onset and 
perpetuation of chronic pain” (p. 1610). This is a very important perspective 
addressed by other authors as well and it suggests a multifactorial understanding of 
chronic pain. In 2004, Serhan and Chiang wrote a review on “resoleomics” [251] (a 
term which Serhan created in 1996). This neologism means the “systematic analysis 
of the resolution phase of inflammation using combined proteomics, lipidomics, and 
genomics to establish the temporal relationship of the key components to 
homeostasis” (p.69). In particular, the authors shed light on the role of the immune 
system in the inflammatory resolution process, putting a great emphasis on evidence 
for the complexity and multiple factors which interconnect the immune system and 
the inflammatory process and which were previously unknown. According to these 
new findings, the inflammatory process should not be viewed as a mere “passive” 
resolution of a stressful local event, but rather as the dynamic orchestration of the 
whole immune system - and, therefore, of the entire body. This understanding is 
critical in relation to this study when considering that specific dietary patterns which 
are considered “anti-inflammatory” (i.e., the fruits and vegetables rich dietary pattern, 
“Mediterranean dietary pattern”, gluten free diet, and n-3 fatty acid enhanced diet) 
have been shown to have a protective effect on the immune system or even enhance 
its performance 
[252-255]
. On the other hand, a protein and carbohydrate-rich diet, or the 
“Western dietary pattern”, which has been shown to be “pro-inflammatory”, has also 
been shown to heighten the reactivity of the immune system, and potentially 
predispose patients to autoimmune diseases 
[203, 256]
. 
 34 
2.3.2 DNA methylation pattern, diet and chronic pain. 
A direct link between DNA methylation pattern and pain has been shown 
in two different studies. The study by Tajerian et al. 
[211]
 demonstrated a link between 
lower DNA methylation levels and low back pain, while Doehring et al. 
[212]
 revealed 
that opioid-induced DNA methylation might be linked to at least part of the painkiller 
effect of opioids. Furthermore, DNA hypomethylation is associated with dietary 
patterns poor in fruits and vegetables, and is believed to be a predisposing factor for 
certain cancers 
[257]
. In contrast, the Mediterranean diet has been associated with relief 
in the oxidative stress of the body and an enhanced ability for DNA repair 
[258]
. Lastly, 
a lower methylation pattern has been associated with a higher peripheral presence of 
blood mononuclear cells 
[259]
, which consist of lymphocytes (T cells, B cells, NK 
cells) and monocytes. More research needs to be done in this area to clarify the role of 
DNA methylation as a possible linking mechanism between chronic pain, diet, 
immune response and inflammatory response.  
 
2.3.3 Gut microbiota, inflammation, diet, and chronic 
pain. 
A possible mediating mechanism between diet and inflammation may 
involve the gut microbiota. Studies have shown that dietary patterns influence the 
lower digestive system state of inflammation by affecting the gut microbiota 
[62, 63]
 
and by creating a local immune inflammatory-type response 
[64, 65]
, which can then 
become chronic and systemic 
[66]
. This means that a systemic inflammation might 
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cause a multi-systemic sensitizing effect which can then lead acute pain to become 
chronic. 
Only one study could be found on the interaction between a decreased 
level of gut microbiota strains and the presence of chronic pelvic pain syndrome 
[260]
. 
This interaction was strong, to the extent that the authors pointed out that the gut 
microbiota could not be only a biomarker for assessing the chronic pelvic pain 
syndrome, but also a potential therapeutic target in addressing the condition. These 
results open up an interesting perspective on the interaction between gut microbiota 
and chronic pain, although more research is needed in the area. 
 
2.3.4 Oxidative state, diet, and chronic pain. 
Oxidative state has been associated with conditions characterized by 
chronic pain, such as chronic fatigue syndrome 
[261-263]
, fibromyalgia 
[264-266]
, and 
chronic daily headaches 
[267]
. The mechanisms mediating this association are still 
unclear. 
A few studies point to specific dietary components 
[201],
 as well as anti-
oxidative supplements 
[261]
, to promote a decrease in the oxidative status, although the 
research in this area is still limited to very few studies. Scientific articles investigating 
a direct link between diet and oxidative state could not be found in current literature. 
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Note 1. 
Literature research was performed on PubMed, PubMed Health, and PMC in May 2015 (and lastly updated in Dec 2016) using 
the following combinations of key words: 
- inflammation AND diet AND chronic pain 
- sub-inflammation AND diet AND chronic pain 
- Chronic inflammation AND diet AND chronic pain 
- Oxidative state AND diet AND chronic pain 
- Immune response AND diet AND chronic pain 
- DNA methylation levels AND dietary intake AND chronic pain 
- inflammation AND dietary intake AND chronic pain 
- sub-inflammation AND dietary intake AND chronic pain 
- Chronic inflammation AND dietary intake AND chronic pain 
- Oxidative state AND dietary intake AND chronic pain 
- Immune response AND dietary intake AND chronic pain 
- DNA methylation levels AND dietary intake AND chronic pain 
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CHAPTER 3: METHODS 
 
3.1 Data source 
3.1.1 The NHANES dataset description 
The present study implements a cross-sectional design using the 2003-
2004 National Health and Nutrition Examination Survey (NHANES) sample 
population.  
The 2003-2004 National Health and Nutrition Examination Survey 
(NHANES) dataset was used for this study. The NHANES is an ongoing program of 
data collection, research and studies for the United States that aims to assess the 
Health and Nutrition status of the general U.S. population. The unique aspect of this 
broad survey is the combination of data collection methods, which happens both 
through interviews and physical examination. The NHANES program is conducted by 
the National Center for Health Statistics (NCHS), which is a department of the 
Centers for Disease Control and Prevention (CDC), the U.S. Public Health Service 
Agency. The NCHS was appointed by the CDC to keep statistical records of the U.S. 
population through recurrent surveys. This particular survey began in 1959 (under the 
name of NHES - National Health Examination Survey) as a way to assess for chronic 
conditions. It has been adapted to the changing needs of relevant information for the 
U.S. and its scientific community. 
Data were collected over two years: each year from approximately 5,000 
participants across 15 U.S. counties (different each year), for a total of approximately 
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10,000 individuals and 30 counties. The data  were then combined for analysis. Data 
from participants  were collected in two distinct ways: health interviews were 
conducted in the participants’ homes, and physical examinations were done in special 
Mobile Examination Centers (MEC) specifically located in areas of interest. 
Interviewers, a significant portion of whom were bilingual, included physicians, 
dentists, medical technicians, health technicians, and dietary and health interviewers. 
Not every participant was administered an interview and a physical exam, though all 
were offered. Some participants declined one component or the other. The 
unweighted response rate for the interviewed sample was 79%, while for the 
examined sampled was 76%. 
For both modalities, data were collected electronically and stored into 
databases. Patients were given privacy to answer sensitive questions; in these cases, 
interviewers were not allowed to see the answer, which was directly typed into the 
computer. 
A comprehensive questionnaire was handed to the participants, and 
included sections on demographics, diet, health status, occupation, insurance 
coverage, physical activity and medications taken. Two portions of this questionnaire 
were relevant to this study: the “24HR dietary recall” section and the “miscellaneous 
pain” section. These portions were handed out on the first day (day 1) in the Mobile 
Examination Center (MEC), or at home for those who agreed only to the interview. A 
second “24HR dietary recall” was administered via phone in a window of time 
between 3 to 10 days after the first one was completed. Most participants (87%) have 
two days of complete intakes. 
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Patients were contacted via mail, and transportation was provided to 
facilitate participation in the study. Participants were given compensation for their 
time. Privacy was strictly kept at the time of data collection for all information and 
data collected, and it is still currently maintained. 
Datasets from NHANES are available on the CDC website 
[68]
 and can be 
downloaded and used freely (except certain sensitive variables data which were not 
used for this study). The response rate of the dataset was 79% in the interviewed 
sample and 76% in the examined sample. 
 
3.1.2 Stages of the NHANES dataset selection process 
 The sample set is a stratified multistage probability selection of the 
civilian non-institutionalized population of the United States. Adolescents (15-19) and 
people over 60 years were oversampled, as well as African Americans and Mexican 
Americans, to validly estimate these groups. The NHANES procedure to recruit the 
sample set consists of the following four stages. 
 
3.1.2.1 Stage 1 – County selection 
Single counties or groups of contiguous counties were selected. Different 
strata were defined according to geography and proportions of minority groups in the 
involved areas. From these strata (counties), Primary Sampling Units (PSUs) were 
then selected. In the majority of cases, there were two PSUs per strata.  
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The method used for the calculation of the distribution across minorities 
was the proportional to a measured size (PPS) to ensure proper representation in the 
final dataset. 
 
3.1.2.2 Stage 2 – Spatial Allocation 
The PSUs were organized into different segments based on spatial 
allocation (i.e., city blocks). Again, the method used for the calculation of probability 
of these sample segments was PPS. 
 
3.1.2.3 Stage 3 – Household selection 
Households were randomly selected from each segment highlighted in 
stage 2. This process was performed respecting the predefined parameters of 
oversampling, wherever necessary. 
 
3.1.2.4 Stage 4 – Individuals’ selection 
Individuals were again randomly selected within the predefined age-sex-
race/ethnicity sub-domains. These people were selected from each of the households 
selected in stage 3.  On average, 1.6 persons were selected per household. 
 
3.1.3 Study sample selection process 
3.1.3.1 Inclusion and exclusion criteria 
The first inclusion criterion imposed for the selection of individuals from 
the dataset was age (ages 20 to 85 were included). This criterion was applied for two 
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reasons. First, the study was designed to target the adult population. Second, only 
individuals between the ages of 20 and 85 have pain variables data reported, while 
data for the 24HR dietary recall is available for individuals between 6 and 85 years of 
age. Therefore, only the age span of 20 to 85 was included in this analysis. 
The other criterion was the presence of data on both the relevant pain 
variables and on the dietary intake, where the latter had to be collected during both 
interview sessions. Only individuals with data collected on both variables were 
included, and if data was missing on either variable, the individual sample was 
excluded from this analysis. Only individuals with dietary intake data collected in 
both occasions of the questionnaire administration were included, to provide more 
reliable information on the intrapersonal variability of diet. 
 
3.1.3.2 Inclusion and exclusion criteria application 
 The initial selection for the sample population included 12,761 
individuals, with age ranging from 0 to 85. Among these subjects, 10,122 were 
interviewed (79.3 percent), and 9,643 (75.6 percent) were given the medical exam. 
For the purpose of this study, all those who received the interview were considered 
initially.  
Upon applying the first inclusion criteria (subject age 20 to 85), the 
sample population size was reduced from 10,122 to 4,818. Within this age-selected 
population, only 3,966 individuals had data on both dietary intake and chronic pain. 
These 3,966 individuals were the study population dataset. 
An additional inclusion criterion was imposed for the tertiary variable of 
pain duration. To be included in this analysis, an individual had to have responded 
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“yes” to the secondary variable question (“in the past month, did you have pain 
lasting longer than 24 hours?”). This last criterion matched for 1,033 individuals in 
the dataset. 
 
3.2 Study Variables 
3.2.1 Dependent variables 
The main outcome (dependent) variable was the presence or absence 
(dichotomous variable) of pain during the three months preceding data collection in 
the neck and/or lower back. This definition is comparable to the commonly accepted 
definition of chronic pain from the International Association for the Study of Pain 
(IASP), which is “pain which has persisted beyond normal tissue healing time”. If no 
other criteria are specified, usually that amount of time is considered to be  three 
months 
[268]
. In the IASP definition, the frequency and consistency of pain during this 
period of time are not specified (e.g., it is not specified if the pain needs to be present 
every day, or the majority of days, or if it should just be a recurring pain in the same 
area). The question asked in the questionnaire (“During the past 3 months, did you 
have neck pain?”) covers the proper amount of time, although it does not clarify the 
exact extent of the pain duration. Further instruction in the question explanation states 
“the following questions are about pain you may have experienced in the past 3 
months. Please refer to pain that lasted a whole day or more. Do not report aches and 
pains that were fleeting or minor”. This indication leaves space for interpretation and 
is a possible source of bias. 
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A secondary dependent variable, namely, the presence or absence 
(dichotomous variable) of pain lasting more than 24 hours during the month 
preceding the interview, was categorized and analyzed as well. This analysis was 
made to help frame the type of pain described in the main outcome variable. A 
scenario where pain lasted more than 24 hours was anticipated to support a situation 
where pain leans more towards chronicity. 
To further investigate this hypothesis, a tertiary analysis was done on the 
subpopulation of people who responded “yes” to having pain lasting longer than 24 
hours in the preceding month. This subpopulation accounted for 1033 individuals. 
The data available for these individuals were divided into four categories: pain lasting 
less than a month, pain present for at least 1 month but less than 3 months, pain for at 
least 3 months but less than 1 year, and pain presence for a period greater than 1 year. 
These categories were collapsed into a dichotomous variable (pain up to three months 
and pain longer than three months) and treated accordingly. The decision for 
collapsing the four categories into two was made based on the clinical relevance of 
the time frame in the definition of chronic pain. 
The variables derived from this questionnaire are coded under the name of 
“miscellaneous pain” (MPQ_C). “Miscellaneous pain” is a group of questions 
administered during the interviewing process. It includes 12 different questions on 
pain (duration, intensity, location, and frequency). The four questions considered for 
this research were coded as question MPQ.060 (pain in the lower back), MPQ.070 
(pain in the neck), MPQ100 (pain lasting longer than 24 hours), and MPQ110 (pain 
duration). Question MPQ.060 and MPQ.070 were merged into one variable (pain 
either in low back, or neck, or both, versus no pain), while question MPQ100, and 
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MPQ110 were merged into a different variable (pain lasting up to three months or 
longer than 3 months). A total of 5411 individuals provided information about their 
pain history. 
 
3.2.2 Main exposure variable  
The main exposure variable was DII, which was treated as a continuous 
variable in the study. The DII was calculated from the raw data available from the 
Food Frequency Questionnaire based on the method described by Shivappa et al. 
[31, 
32, 37, 44, 59]
, and discussed in section 2.2.3.1 and further in this section. 
The data used to calculate the DII were collected as part of the 
questionnaire (“24HR dietary recall”) that was handed out the first day (day 1) in the 
Mobile Examination Center (MEC), or at home for those who agreed to the interview 
only. A second “24HR dietary recall” questionnaire was administered via phone in a 
window of time between 3 to 10 days after the first one was completed. Most 
participants (87 percent) had 2 days of complete intakes. 
Calculation of the DII was made based on quantity and frequency of 
consumption of 28 specific food item values. In the original review, 45 items were 
recognized, but, in line with previous researchers 
[32, 34]
, a lower number (28) of items 
were analyzed. The included food items were identified from the questionnaire as 
matching those from the “golden standard” values coming from the original literature 
review performed to construct the DII in 2014. More specifically, the DII has been 
calculated by first linking the dietary data to one of the 11 regionally representative 
world databases (described in section 2.2.3.1), which are based on different diets 
highlighted from the systematic review. This systematic review provides a mean and 
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standard deviation for each food parameter 
[37]
, which is considered the “standard 
global mean”. 
The “standard global mean” was then subtracted from the individual's 
value of each food item consumption recorded (the data registered with the 
questionnaire) and divided by the standard deviation. The individual food item 
consumption was calculated by averaging the mean of the total Nutrient Intakes (File 
Coded as DR1TOT_C and DR2TOT_C) for the nutrients of interest from the two 
days of collection.  
These data were converted to a centered percentile to avoid the common 
occurrence (for dietary data analysis) of “right skewing”. This phenomenon describes 
a positive skewing, resulting in a longer right tail on the distribution curve, and which 
requires advanced statistical measurements to analyze appropriately. In order to avoid 
complicated analysis, the data were converted to a centered percentile. The centered 
percentile was then multiplied by the effect score (gathered for each specific food in 
the literature review 
37
). This method provides a DII score that is parameter-specific 
for the individual.  
The final DII score for each person represents the sum of the 28 items’ 
value calculated for each individual relative to the global diet dataset. This value 
represents the overall tendency of one's diet to be pro-inflammatory or anti-
inflammatory. In line with previous studies, the value of this variable was between -
7.5 (diet overall anti-inflammatory) and +8.5 (diet overall pro-inflammatory). For the 
purpose of statistical analysis, the DII was treated as a continuous variable, based on 
current literature findings 
[33, 269-271]
.  
The independent variable contains the most data entries, a total amount of 
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9,643, although only 9,034 provided completed data. Of this figure, only 8,354 
individuals completed both days’ interviews. 
 
3.2.3 Covariates 
Based on literature review 
[21, 46, 55, 193, 199, 211, 212, 214, 272-283]
, many relevant 
and consistent confounders related to pain and sub-inflammation collected in the 
survey were examined. The following possible confounders were investigated: age 
[284]
, gender 
[285]
, BMI 
[286]
, physical activity level 
[287]
, education level 
[55]
, diagnosis 
of diabetes 
[288]
, race/ethnicity 
[289]
, general health condition 
[290]
, total annual income 
[291]
, marital status 
[292]
, number of people per household 
[293]
, and insurance cover 
[199]
. 
Age (calculated in months), and BMI (calculated as height/weight; in cm 
and kg) were treated as continuous variables. The other variables were categorical and 
were treated as described here. Physical activity level was divided into four levels: 1- 
sit much during the day and do not walk much; 2- stand or walk about a lot during the 
day, but do not have to carry or lift things very often; 3- lift light load or climb stairs 
or hills often; 4- perform heavy work or carry heavy loads. Sex was divided into male 
and female. Education level was divided into three groups: 1- less than high school 
diploma; 2- high school diploma; 3- more than high school diploma. Diagnosis of 
diabetes was classified into three categories: 1- yes, 2- no, and 3- borderline according 
to the question “did your doctor tell you that you have diabetes?”. Race/ethnicity was 
divided into five groups: 1- Mexican American, 2- Other Hispanic, 3- White Non-
Hispanic, 4- Black Non-Hispanic, 5- Other Race (which includes multi-racial). 
General health condition was divided into five groups as well: 1- excellent, 2- very 
good, 3- good, 4- fair, 5 -poor. Total Annual Household Income was divided into four 
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groups: 1- up to 20,000$/year; 2- up to 45,000$/year; 3- up to 75,000$/year; 4- over 
75,000$/year. Marital status was divided into two groups, 1- married / living with a 
partner and 2- never married, separated, divorced, widowed.  Number of people per 
household was divided into 5 categories: 1- one, 2- two, 3- three, 4- four and 5- five 
or more people living in the household. Insurance coverage was dichotomized into 
yes/no. 
Other known confounders (e.g., smoking status) were not considered due 
to the high number of missing values. 
 
3.3 Statistical analysis 
The statistical software used for all analyses was SAS 9.4 for Windows 
(SAS Institute Inc., Cary, NC, USA). 
 
3.3.1 Population baseline characteristics 
Baseline characterization of the population over 20 years old of age was 
made to compare the included individuals who had dietary information available and 
the excluded individuals who did not have the dietary information available. 
Pearson’s 2 test was used to compare the baseline characteristics for the 
categorical variables (gender, physical activity level, education level, diagnosis of 
diabetes, race/ethnicity, general health condition, annual income, marital status, 
number of people per household, and insurance cover). The t-test was used to 
compare the baseline characteristics for the continuous variables (age and BMI).  
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3.3.2 Sample weight for dietary intake data 
The population data selected for this study were analyzed through 
complex probability sample, and sample weight information provided with the 
NHANES dataset was utilized in all analyses, including descriptive analysis. 
Description of the weight rules used in this population data analysis is in the 
following paragraph. 
The majority of the 2003-2004 NHANES dataset is designed to be 
analyzed using the weight for data collected in the MEC centers (weight code: 
WTMEC2YR). When it comes to dietary data though, the weights to be used are 
different. This difference depends on the fact that data were collected 
disproportionally more during weekends, which would cause an underrepresentation 
of food consumed during week days versus food consumed during weekends. This is 
based on the understanding that food is consumed differently in different days of the 
week. 
To overcome this sampling bias, there are two different weights provided 
with the dataset designed to be used when performing statistical analysis on dietary 
variables. A specific weight (WTDRD1) has been calculated for individuals who 
answered only the first of the two 24HR questionnaires. This weight was constructed 
using the MEC sample weight (WTMEC2TR), and adjusted for (1) additional non-
response, and (2) different day-of-the-week allocation for the dietary intake data 
collection. This weight has no direct application for this study, since the inclusion 
criteria allow only data from individuals with information from both interviews.  
The weight that was used for this study was another specific weight, 
coded WTDR2D. This two-day weight was constructed for the 8,354 respondents 
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who entered valid data from the two recalls. This weight is calculated by taking the 
Day 1 weights (WTDRD1) and computing an adjustment for (1) additional non-
response for the second recall and (2) the proportion of combinations of different days 
of the week for Day 1 and Day 2 recalls.  
The WTDR2D sampling weight was applied in all statistical analysis 
including descriptive, univariate, and multivariate analysis. This weight has been 
normalized through the following process: first, the average of all the survey weights 
from all analyzed units was calculated; then, the survey weight of each unit used in 
the analysis was divided by that average. Bootstrap weights were not used for this 
study. The SAS command used for this computation was PROC LOGISTIC with the 
addition of the command WEIGHT, followed by the name of the normalized weight 
variable. 
 
3.3.3 Dietary Inflammatory Index and Neck/Low back 
pain (main outcome variable) 
The main exposure variable (DII) was tested as a continuous variable.  
The main outcome variable, presence/absence of chronic pain in the neck and/or 
lower back, was treated as a dichotomous variable.  
A logistic regression model was used to identify the significant factors 
associated with chronic pain. Odds Ratio and 95% CI were calculated. All covariates 
were tested for interaction as effect modifiers as well as confounders. 
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3.3.4 Dietary Inflammatory Index and pain lasting 
more than 24hr over a one-month period 
(secondary outcome variable) 
The independent continuous variable of DII was tested against the 
dependent dichotomous variable of presence/absence of any pain present for more 
than 24hr over the month before the interview.  
A logistic regression model was used to identify the significant factors 
associated with chronic pain. Odds Ratio and 95% CI were calculated for the 
regression model. All covariates were tested for interaction as effect modifiers as well 
as confounders. 
 
3.3.5 Dietary Inflammatory Index and pain duration 
(tertiary outcome variable) 
The independent continuous variable of DII was tested against the 
dependent dichotomous variable of pain lasting less than three months versus pain 
lasting longer than three months.  
A logistic regression model was used to identify the significant factors 
associated with chronic pain. Odds Ratio and 95% CI were calculated for the 
regression model. All covariates were tested for interaction as effect modifiers as well 
as confounders. 
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3.3.6 Final Model construction 
The final model construction initially included all the variables which 
were deemed significant in the univariate analysis at α=0.20. The final model 
construction was then performed using a manual method, and a likelihood ratio test 
for significant difference was conducted. One at  a time, all the non-significant 
variables (p>.05) were removed, by taking away one at the time the least significant, 
until a significant difference in the model was detected. All the included variables 
were tested for interaction and possible confounding effect. The threshold for 
detecting a significant change in the main effect variable (beta coefficient) when 
removing covariates from the model was set at 20%. All the continuous variables 
were also assessed for linearity by testing for correlation between dependent variable 
and independent variables. Outliers were assessed for with Cook’s method. Model fit 
was test with Hosmer and Lameshow’s diagnostic plots. 
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CHAPTER 4: RESULTS 
 
4.1 Baseline characteristics analysis 
4.1.1 Included vs. excluded population >20yrs old. 
An analysis of the baseline characteristics of the included (3,966 
participants) versus excluded (848 participants) populations over 20 years old was 
performed (Table 1). There were no significant differences in diagnosis of diabetes, 
self-reported general health condition, and mean age between the two groups. 
Significant differences were found in the other confounders.  
The included population had a significantly higher number of women and 
a higher prevalence of education level greater than high school when compared with 
the excluded population. Analysis to the variable of physical activity level performed 
each day showed that the included population had a lower prevalence of heavy 
workers, compared to any other activity level assessed. A higher prevalence of 
married people was observed in the included population, and race/ethnicity for the 
included population had a higher prevalence of non-Hispanic white, and a lower 
prevalence of non-Hispanic black and other ethnicities compared with the excluded 
population. The variable of number of people per household showed that the included 
population had a higher prevalence of 2 people per household compared to any other 
household size. The included population had a higher rate of insurance coverage 
compared to the excluded population. Annual income for the included population was 
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higher than the excluded population, with a higher prevalence of income over 
45.000$/year. Lastly, BMI mean was higher in the included population. 
 
Table 1.  Baseline characteristics of included versus excluded population 
(> 20yrs old). (Note that missing values are not specified if not present). 
Baseline characteristics 
(population >20 years old) 
(*= Significant value) 
Excluded 
population 
n=848 
(%) 
Included 
population 
n=3966 
(%) 
p-value 
Gender 
Male 
Female 
 
51.80 
48.20 
 
47.43 
52.57 
 
0.0255* 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
Missing 
 
47.46 
28.12 
23.78 
0.64 
 
16.76 
26.72 
56.49 
0.04 
 
<.0001* 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
Missing 
 
25.47 
49.55 
13.45 
11.51 
0.02 
 
24.01 
51.11 
17.33 
7.49 
0.06 
 
0.0005* 
Diabetes 
Yes 
No 
Borderline 
 
7.12 
91.69 
1.20 
 
7.82 
91.04 
1.14 
 
0.7922 
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Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
Missing 
 
54.21 
45.30 
0.48 
 
65.67 
34.26 
0.07 
 
<.0001* 
Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
8.55 
3.13 
63.57 
14.86 
9.89 
 
7.72 
3.77 
73.15 
10.56 
4.79 
 
<.0001* 
Number of people per household 
1 
2 
3 
4 
5+ 
 
18.94 
28.22 
19.83 
18.60 
14.42 
 
12.29 
36.18 
18.02 
16.64 
16.86 
 
<.0001* 
Insurance cover 
Yes 
No 
Missing 
 
72.90 
23.55 
3.55 
 
82.22 
17.15 
0.64 
 
<.0001* 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
Missing 
 
20.19 
25.89 
32.71 
16.49 
4.6 
0.09 
 
21.47 
30.25 
30.91 
13.44 
3.90 
0.04 
0.0525 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
 
19.09 
29.86 
20.50 
 
5.00 
15.89 
29.43 
 
<.0001* 
 55 
over 75.000$/year 
Missing 
19.17 
11.38 
23.42 
26.26 
BMI 
Mean 
95% CI 
 
27.19 
26.72 - 27.67 
 
28.41 
28.21 - 28.61 
 
<.0001* 
Age 
Mean 
95% CI 
 
44.9 
43.7 – 46.0 
 
46.3 
45.8 – 46.8 
 
0.9686 
 
 
4.1.2 Study population: individuals with CP vs. 
individuals without CP. 
An analysis of the baseline characteristics was then performed within the 
included population, comparing individuals with chronic pain (n=2116) to those 
without chronic pain (n=1850) (summarized results shown in Table 2). This analysis 
shows significant differences between the two groups. These differences were found 
for the gender variable, where the CP population had higher women prevalence. 
Regarding education level, the CP population had a higher prevalence of lower than 
high school diploma education. The level of physical activity performed each day had 
a higher prevalence of both lower activity level and heavy lifting in the CP 
population, while non-CP population had higher prevalence of light to medium daily 
activity. The diagnosis of diabetes was more prevalent for the CP population. 
Additionally, the CP population had higher prevalence of non-Hispanic white and a 
lower prevalence of Mexican American. Self-reported general health condition of the 
lower quality categories – namely good, fair and poor had higher prevalence in the CP 
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population, whereas the non-CP population had higher prevalence of the very good 
and excellent categories. Average annual income was lower for the CP population, 
while BMI mean was higher for the CP population. The two populations were found 
to be non-significantly different in regards to marital status, number of people per 
household, insurance coverage, and mean age. 
To control for these unbalances, the baseline characteristics that were 
found different in this analysis were adjusted for in the multivariate analysis 
performed to find the final model. 
 
Table 2. Baseline characteristics of individuals with CP versus individual 
without CP in the included population. (Note that missing values are not specified if 
not present). 
Baseline characteristics 
     (study population) 
   (*= Significant value) 
Non-chronic 
pain population 
n= 1850 
(%) 
Chronic pain 
population 
n= 2116 
(%) 
p-value 
Gender 
Male 
Female 
 
50.83 
49.17 
 
43.54 
56.46 
 
<.0001* 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
14.88 
25.15 
59.97 
 
18.96 
28.53 
52.51 
 
<.0001* 
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Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
 
22.77 
52.00 
18.48 
6.75 
 
25.41 
50.16 
16.04 
8.39 
 
 
0.0152* 
 
Diabetes 
Yes 
No 
Borderline 
 
6.26 
92.81 
0.93 
 
9.61 
89.02 
1.37 
 
0.0002* 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
64.89 
35.11 
 
66.70 
33.30 
 
0.2311 
Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
8.54  
3.65 
71.35 
11.42 
5.04 
 
6.82 
3.91 
75.17 
9.59 
4.50 
 
0. 0475* 
Number of people per household 
1 
2 
3 
4 
5+ 
 
11.89 
36.09 
18.36 
17.01 
16.65 
 
12.71 
36.29 
17.64 
16.25 
17.11 
 
0. 8620 
Insurance cover 
Yes 
No 
Missing 
 
82.47 
16.87 
0.66 
 
81.88 
17.51 
0.61 
 
0. 8523 
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General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
27.09 
32.88 
28.84 
9.04 
2.15 
 
15.06 
27.27 
33.25 
18.48 
5.94 
<.0001* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
Missing 
 
13.46 
27.68 
25.95 
28.38 
4.54 
 
18.63 
31.48 
20.52 
23.85 
5.52 
 
<.0001* 
BMI 
Mean 
95% CI 
 
28.13 
27.86 - 28.39 
 
28.73 
28.43 - 29.04 
 
0.0020* 
Age (in months) 
Mean 
95% CI 
 
45.9 
45.2 – 46.5 
 
46.7 
46.0 – 47.4 
 
0.2991 
 
 
4.2 Main variable 
4.2.1 Univariate analysis 
Univariate analysis was conducted on each of the covariates to assess the 
effect of each of them on chronic pain in the lower back and in the neck (Table 3). 
The DII effect on the dependent variable was also assessed at this point. In this 
population, a significant effect on the presence of chronic pain was found for gender, 
education level, level of physical activity performed each day, diagnosis of diabetes, 
race/ethnicity, self-reported general health condition, annual income, BMI, and DII.  
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The DII was found to be significant with a p-value of .0099, with an OR 
of 1.036. To better understand this result, it is important to remember that Odds 
Ratios measure the unit of the variable in question. The DII ranges between -7.5 and 
+8.5, therefore having an overall range of 16 points. The chances of having chronic 
pain are 3.6% higher for every 1-point increase in the DII score. Therefore, to 
calculate the OR for a 3 point difference in DII score, the score difference is 
multiplied by the estimate “” from the logistic regression (0.0356 X 3 = 0.1068). The 
calculation of the exponential for this value (e
0.1068
) gives an OR value of 1.1127. This 
means that a 3 points difference in the DII scale would change the odds of having 
chronic pain by 11.27%.  
Similarly, to calculate the OR for a 9 points difference in DII score, the 
same calculation would be (0.0356 X 9 = 0.3204); the result would then be used to 
calculate the exponential (e
0.3204
) which gives an OR value of 1.3776. This result 
means that a 9 points difference in the DII scale would change the odds of having 
chronic pain by 37.76%.  
In addition, to give an example based on the full range of the DII and 
calculate the OR based on a 16 points difference in DII score, the calculation would 
be (0.0356 X 16 = 0.5696). The computation of the exponential for this value (e
0.5696
) 
gives as a result OR= 1.7676. This means that a 16 points difference in the DII scale 
would change the odds of having chronic pain by 76.76%. This last result, although 
probably not clinically relevant, highlights the full potential of the different impact 
that a fully anti-inflammatory diet can have compared to a fully pro-inflammatory 
diet. 
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Table 3. Univariate analysis of covariates and DII effect on chronic pain 
presence 
Univariate analysis: DII on CP 
(study population; n= 3966) 
(*= Significant value) 
Analysis of 
Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.317 (1.158 - 1.498)* 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
 
p= <.0001* 
 
1.00 
0.890 (0.729 - 1.088) 
0.676 (0.565 - 0.808)* 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0.0174* 
 
1.00 
0.910 (0.695 – 1.192) 
0.767 (0.595 - 0.988)* 
0.713 (0.537 - 0.946)* 
Diabetes 
Yes 
No 
Borderline 
 
 
p= 0.0006* 
 
1.00 
0.649 (0.508 - 0.828)* 
1.116 (0.576 - 2.159) 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
p= 0.3018 
 
1.00 
1.074 (0.938 - 1.230) 
Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= 0.0465* 
 
0.748 (0.584 - 0.957)* 
1.015 (0.725 - 1.419) 
1.00 
0.784 (0.633 - 0.970)* 
0.894 (0.660 - 1.212) 
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Number of people per household 
1 
2 
3 
4 
5+ 
 
 
 
p= 0.9006 
 
1.00 
1.038 (0.817 - 1.319) 
0.992 (0.821 - 1.198) 
0.949 (0.764 - 1.178) 
0.932 (0.745 - 1.165) 
Insurance cover 
Yes 
No 
 
p= 0.6950 
 
1.00 
0.966 (0.815 - 1.146) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
1.531 (1.267 - 1.850)* 
2.156 (1.788 - 2.600)* 
3.780 (2.992 - 4.776)* 
5.385 (3.656 - 7.933)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= <.0001* 
 
1.00 
0.815 (0.671 - 0.990)* 
0.566 (0.461 - 0.695)* 
0.606 (0.496 - 0.739)* 
BMI p= 0.0031* 1.015 (1.005 - 1.025)* 
Age (in months) p= 0.0651 1.000 (1.000 - 1.001) 
DII p= 0.0099* 1.036 (1.009 - 1.065)* 
 
 
4.2.2 Multivariate analysis 
Multivariate analysis, summarized in table 4, was performed on all 
variables deemed significant at a .20 level in the univariate analysis. The included 
variables were gender, education level, level of physical activity performed each day, 
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diagnosis of diabetes, race/ethnicity, self-reported general health condition, annual 
income, BMI, and DII. In this model, the DII was found to be non-significant, with a 
p-level of 0.0610. Other non-significant variables were age, education level, level of 
physical activity performed each day, diagnosis of diabetes, race/ethnicity, and BMI. 
 
Table 4.  Multivariate analysis of covariates and DII effect on chronic 
pain presence – First Model 
Multivariate analysis: DII on CP 
     (study population) 
  (*= Significant value) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.407 (1.224 - 1.616)* 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
 
p= 0. 3614 
 
1.00 
0.965 (0.772 - 1.205) 
0.877 (0.707 - 1.087) 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0. 0457* 
 
1.00 
0.958 (0.809 - 1.135)* 
0.980 (0.790 - 1.216)* 
1.417 (1.056 - 1.902)* 
Diabetes 
Yes 
No 
Borderline 
 
 
p= 0. 7634 
 
1.00 
0.960 (0.730 - 1.263) 
1.219 (0.598 - 2.487) 
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Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= <.0001* 
 
0.549 (0.416 - 0.725)* 
0.874 (0.612 - 1.249) 
1.00 
0.629 (0.499 - 0.793)* 
0.852 (0.620 - 1.172) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
1.538 (1.268 - 1.866)* 
2.143 (1.756 - 2.616)* 
3.661 (2.834 - 4.730)* 
5.718 (3.717 - 8.796)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= 0. 0157* 
 
1.00 
0.911 (0.741 - 1.120) 
0.717 (0.574 - 0.895)* 
0.861 (0.688 - 1.079) 
BMI p= 0. 5355 1.004 (0.992 - 1.015) 
Age p= 0.2983 1.000 (0.999 - 1.000) 
DII p= 0. 1225 1.024 (0.994  - 1.056) 
 
 
A stepwise selection method to find the best fitting model was performed 
with all variables included in the multivariate analysis. This procedure revealed that 
gender, self-reported general health condition, BMI, and DII were significant in 
defining a statistical model for all analyzed variables. When the multivariate analysis 
was run again with only these four variables considered (Table 5), DII was found to 
be significant, although with a weak strength (p-value= 0.0346; OR= 1.031). 
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Additionally, annual income was significant with a weak association (p-value = 
0.0270). In contrast, gender and general health condition instead, were significant at a 
<.0001 level. The interaction between these four variables was analyzed by running a 
separate multivariate analysis for each of the possible interactions between factors, 
and none was found to be significant. 
The DII therefore has a significant association with the presence of 
chronic pain when gender, general health condition, and annual income are taken into 
account. This is the best-fit model for this population when gender, age (calculated in 
months), marital status, number of people per household, insurance cover, education 
level, level of physical activity performed each day, diagnosis of diabetes, 
race/ethnicity, self-reported general health condition, annual income, BMI, and DII 
are considered. With this multivariate model, the Odds Ratio for DII have similar 
values to those calculated in the example for the univariate analysis. In this case, 
when using the same calculation method described in section 4.2.1 of this chapter 
(using a  value of .0304), the OR calculations yielded the following results: OR= 
1.0954, when calculating the difference in odds for chronic pain with a 3-points 
difference in the DII. OR= 1.3147, when calculating the difference in odds for chronic 
pain with a 9-points difference in the DII; OR= 1.6265, when calculating the 
difference in odds for chronic pain with a 16-points difference in the DII. 
These results suggest that the relevance of the DII in association with 
chronic pain in the neck or lower back is affected, but not compromised, by the 
adjustment to variables relevant in this context. 
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Table 5. Multivariate analysis of covariates and DII effect on chronic pain 
presence after manual selection method - final model. 
Multivariate analysis: DII on CP 
     (study population) 
  (*= Significant value) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.408 (1.226 - 1.618)* 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0.0208* 
 
1.00 
0.962 (0.813 - 1.138) 
0.985 (0.794 - 1.221) 
1.472 (1.101 - 1.967)* 
Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= <.0001* 
 
0.582 (0.447 - 0.757)* 
0.906 (0.636 - 1.291) 
1.00 
0.643 (0.512 - 0.808)* 
0.857 (0.624 - 1.176) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
1.530 (1.262 - 1.855)* 
2.148 (1.763 - 2.616)* 
3.722 (2.902 - 4.775)* 
5.846 (3.842 - 8.894)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
 
p= 0.0098* 
 
1.00 
0.900 (0.733 - 1.105) 
0.704 (0.566 - 0.876)* 
0.834 (0.671 - 1.037) 
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BMI p= 0.5196 1.004 (0.993 - 1.015) 
DII p= 0.0430 1.030 (1.001 - 1.061) 
 
 
4.3 Secondary variable 
4.3.1 Univariate analysis 
Table 6 below shows the results of analysis performed on the secondary 
variable of pain lasting more than 24 hours in the month before the interview. This 
analysis tested for significant association with DII levels, as well as all the covariates 
that were analyzed with chronic pain in lower back and/or neck. A significant 
association was found for gender, level of physical activity, diagnosis of diabetes, 
marital status, race/ethnicity, general health condition, annual income, BMI, and DII. 
Four variables were found to be non-significantly correlated with pain lasting more 
than 24 hours: education level, number of people per household, insurance coverage, 
and age. 
The DII was found to be highly significant in the association with pain 
lasting more than 24 hours (p=<.0001; OR= 1.073). OR calculations gave the 
following results using the same calculation method described in section 4.2.1 of this 
chapter: OR= 1.2355, when calculating the difference in odds for chronic pain with a 
3-points difference in the DII; OR= 1.8861, with a 9-points difference in the DII; 
OR= 3.0895, when calculating the difference in odds for chronic pain with a 16-points 
difference in the DII. 
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These results highlight the importance of the DII levels when the presence 
of pain lasting longer than 24 hours is considered. This association is stronger than 
that between DII and chronic pain presence in the neck and/or lower back. 
 
Table 6.  Univariate analysis of covariates: DII effect on pain lasting more 
than 24hr in the past month 
Univariate analysis:  
DII on Pain >24hrs 
(study population n= 3966) 
(*= Significant value) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.394 (1.208 - 1.608)* 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
 
p= 0. 2181 
 
1.00 
1.030 (0.833 - 1.274) 
0.902 (0.745 - 1.091) 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0. 0422* 
 
1.00 
1.247 (0.922 - 1.687) 
1.014 (0.761 - 1.350) 
1.246 (0.908 - 1.708) 
Diabetes 
Yes 
No 
Borderline 
 
 
p= 0.0006* 
 
1.00 
0.614 (0.478 - 0.789)* 
0.546 (0.261 - 1.141) 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
p= 0. 0211* 
 
1.00 
1.196 (1.027 - 1.392)* 
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Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= 0. 0001* 
 
0.485 (0.353 - 0.664)* 
0.826 (0.564 - 1.208) 
1.00 
0.800 (0.630 - 1.017) 
1.029 (0.742 - 1.428) 
Number of people per household 
1 
2 
3 
4 
5+ 
 
 
 
p= 0. 4159 
 
1.00 
1.032 (0.818 - 1.303) 
0.943 (0.725 - 1.227) 
1.173 (0.900 - 1.529) 
0.959 (0.734 - 1.253) 
Insurance cover 
Yes 
No 
 
p= 0.7058 
 
1.00 
1.037 (0.858 - 1.254) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
2.133 (1.659 - 2.741)* 
3.701 (2.906 - 4.714)* 
5.553 (4.225 - 7.297)* 
13.729 (9.208 - 20.471)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= <.0001* 
 
1.00 
0.828 (0.674 - 1.017) 
0.498 (0.396 - 0.625)* 
0.742 (0.600 - 0.917)* 
BMI p= <.0001* 1.024 (1.013 - 1.035)* 
Age (in months) p= 0.2111 1.000 (1.000 - 1.001) 
DII p= <.0001* 1.073 (1.042 - 1.106)* 
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4.3.2 Multivariate analysis 
When considering DII and the outcome variable of “pain lasting longer 
than 24 hours”, multivariate analysis (Table 7) was performed including all the 
variables deemed significant at a .20 level in the univariate analysis, with the results 
given in Table 7 below. The included variables were gender, education level, level of 
physical activity performed each day, diagnosis of diabetes, marital status, 
race/ethnicity, self-reported general health condition, annual income, BMI, and DII. 
In this model DII was again found to be highly significant, with a p-value 
of <.0001. Two covariates lost their significance in this model (diagnosis of diabetes 
and BMI). 
 
Table 7. Multivariate analysis of covariates and DII effect on pain lasting 
more than 24hr in the past month – initial model. 
Multivariate analysis:  
DII on Pain >24hrs 
     (study population) 
Analysis of 
Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.662 (1.416 - 1.951)* 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0. 0021* 
 
1.00 
1.021 (0.842 - 1.237) 
1.491 (1.169 – 1.901)* 
1.289 (0.922 - 1.802) 
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Diabetes 
Yes 
No 
Borderline 
 
 
p= 0.1275 
 
1.00 
1.097 (0.820 - 1.467) 
0.507 (0.227 – 1.134) 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
p= <.0001* 
 
1.00 
1.429 (1.197 - 1.705)* 
Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= <. 0001* 
 
0.348 (0.248 - 0.489)* 
0.715 (0.471 - 1.086) 
1.00 
0.639 (0.489 - 0.834)* 
1.124 (0.790 - 1.598) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
2.218 (1.709 - 2.878)* 
4.201 (3.239 – 5.450)* 
6.863 (5.076 – 9.279)* 
19.997(12.760 – 31.277)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= <.0001* 
 
1.00 
0.893 (0.711 - 1.123) 
0.566 (0.437 - 0.733)* 
1.033 (0.803 – 1.330) 
BMI p= 0.1859 1.008 (0.996 - 1.021) 
DII p= <.0001* 1.073 (1.037 - 1.110)* 
 
A stepwise selection method was then performed with all variables 
included in the multivariate analysis that were found to be significant at least at a .20 
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p-level. This procedure found that gender, level of physical activity performed each 
day, marital status, race/ethnicity, self-reported general health condition, annual 
income, and DII were significant and relevant in defining a statistical model for the 
analyzed variables. When the multivariate analysis was run again, this time adjusted 
for these variables (Table 8), DII was highly significant with a p-value of <.0001 and 
an OR of 1.079. The level of physical activity was significant with a p-value of 
0.0021, and all other variables were significant at a <.0001 level. The interactions 
between these four variables were analyzed by running a separate multivariate 
analysis for each of the possible interactions between factors, and none were found to 
be significant. 
 
Table 8.  Multivariate analysis of DII effect pain lasting more than 24hr in 
the past month after manual selection method (Final model). 
Final Model: DII on Pain >24hrs 
     (study population) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= <.0001* 
 
1.00 
1.601 (1.367 - 1.875)* 
Level of daily physical activity 
sit during the day and do not walk about very much 
walk a lot during the day, do not carry or lift things very often 
lift light load or have to climb stairs or hills often 
do heavy work or carry heavy loads 
p= 0. 0021* 
 
1.00 
0.958 (0.809 - 1.133) 
0.973 (0.785 - 1.206) 
1.465 (1.097 - 1.957)* 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
p= <.0001* 
 
1.00 
1.425 (1.197 - 1.695)* 
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Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= <. 0001* 
 
0.571 (0.439 - 0.743)* 
0.934 (0.655 - 1.333) 
1.00 
0.675 (0.537 - 0.848)* 
0.866 (0.631 - 1.190) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
2.197 (1.700 - 2.841)* 
4.213 (3.270 – 5.426)* 
6.688 (4.995 – 8.954)* 
17.481(11.416 – 26.770)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= <.0001* 
 
1.00 
0.912 (0.728 - 1.143) 
0.590 (0.458 - 0.761)* 
1.072 (0.835 – 1.375) 
DII p= <.0001* 1.079 (1.044 – 1.115)* 
 
 
4.4 Tertiary variable 
4.4.1 Univariate analysis 
For the population who experienced pain for more than 24 hours, 
univariate analysis was also performed on the tertiary variable of pain duration, with 
the results presented in Table 8 below. This variable was dichotomized into pain 
length longer than 24 hours but shorter than three months and pain length longer than 
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three months. This analysis found a significant association between pain duration and 
DII levels (p= 0.0164; OR= 1.012; 95%CI= 1.042 – 1.124). 
 
Table 9.  Univariate analysis of covariates: DII effect on pain duration. 
Univariate analysis:  
DII on Pain Duration 
(study population n= 1033) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Gender 
Male 
Female 
 
p= 0.9216 
 
1.00 
1.012 (0.794 - 1.290) 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
 
p= 0.0004* 
 
1.00 
0.861 (0.590 - 1.256) 
1.483 (1.061 – 2.072)* 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0.0002* 
 
1.00 
1.438 (1.063 – 1.945)* 
1.973 (1.364 – 2.854)* 
2.489 (1.512 – 4.097)* 
Diabetes 
Yes 
No 
Borderline 
 
 
p= 0.0816 
 
1.00 
0.627 (0.407 – 0.965)* 
1.074 (0.262 – 4.403) 
Marital status 
Married or living with a partner 
Widowed, divorced, separated, never married 
 
p= 0.8290 
 
1.00 
0.971 (0.743  - 1.268) 
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Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= 0. 0037* 
 
1.573 (0.883 – 2.802) 
3.262 (1.646 – 6.461)* 
1.00 
1.473 (0.972 – 2.234) 
1.121 (0.639 - 1.967) 
Number of people per household 
1 
2 
3 
4 
5+ 
 
 
 
p= 0.0045* 
 
1.00 
1.566 (1.015 – 2.416)* 
1.450 (0.890 - 2.362) 
2.377 (1.475 – 3.832)* 
1.969 (1.209 – 3.206)* 
Insurance cover 
Yes 
No 
 
p= 0.1363 
 
1.00 
0.780 (0.563 - 1.082) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
1.354 (0.864 - 2.122) 
1.731 (1.127 – 2.659)* 
4.423 (2.709 - 7.220)* 
8.222 (4.126 – 16.385)* 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= <.0001* 
 
1.00 
1.546 (1.074 – 2.226)* 
1.200 (0.786 – 1.831) 
2.853 (1.965 – 4.142)* 
BMI p= 0.9486 1.001 (0.983 - 1.019) 
Age (in months) p= <.0001* 0.998 (0.997 – 0.998)* 
DII p= 0.0164* 1.012 (1.042 - 1.124)* 
 
 75 
4.4.2 Multivariate analysis 
Regarding DII and the outcome variable of pain duration, multivariate 
analysis was performed including all the variables deemed significant at a .20 level in 
the univariate analysis. The results of this multivariate analysis are given below in 
Table 9. Variables included in the analysis were education level, level of physical 
activity performed each day, race/ethnicity, number of people per household, self-
reported general health condition, annual income, age, and DII. The two variables of 
diagnosis of diabetes and BMI were not included in this analysis. 
In this model, the DII was found to be non-significant, with a p-value of 
0.2956. Stepwise analysis was not performed since the DII p-value exceeded the 
previously imposed cut-off point of .20. 
 
Table 10.  Multivariate analysis of covariates: DII effect on pain duration. 
Multivariate analysis:  
DII on Pain Duration 
(study population n= 1033) 
Analysis of Maximum 
Likelihood Estimates 
OR and 95% CI 
Education level 
Less Than High School 
High School Diploma 
More Than High School 
 
 
p= 0.0029* 
 
1.00 
0.481 (0.313 – 0.741) 
0.691 (0.457 – 1.046) 
Level of daily physical activity 
Sit during the day and do not walk about very much 
Walk a lot during the day, do not carry or lift things very often 
Lift light load or have to climb stairs or hills often 
Do heavy work or carry heavy loads 
p= 0.1737 
 
1.00 
1.184 (0.846 – 1.657) 
1.361 (0.903 – 2.051) 
1.827 (1.031 – 3.240) 
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Race/Ethnicity 
Mexican American 
Other Hispanic 
Non-Hispanic White 
Non-Hispanic Black 
Other Race – Including Multi-Racial 
 
 
 
p= 0.5839 
 
1.573 (0.883 – 2.802) 
3.262 (1.646 – 6.461) 
1.00 
1.473 (0.972 – 2.234) 
1.121 (0.639 - 1.967) 
Number of people per household 
1 
2 
3 
4 
5+ 
 
 
 
p= 0.7572 
 
1.00 
1.566 (1.015 – 2.416) 
1.450 (0.890 - 2.362) 
2.377 (1.475 – 3.832) 
1.969 (1.209 – 3.206) 
General health condition 
Excellent 
Very good 
Good 
Fair 
Poor 
 
 
 
p= <.0001* 
 
1.00 
1.483 (0.749 – 2.937) 
3.485 (1.815 – 6.693) 
4.298 (2.177 – 8.486) 
5.431 (2.550 – 11.567) 
Annual Income 
up to 20.000$/year 
20.000 to 45.000$/year 
45.000 to 75.000$/year 
over 75.000$/year 
p= 0.0005* 
 
1.00 
1.480 (0.996 – 2.200) 
0.997 (0.629 – 1.581) 
2.145 (1.370 – 3.358) 
Age (in months) p= 0.0004* 0.998 (0.998 – 0.999) 
DII p= 0.2956 1.033 (0.972 - 1.099) 
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CHAPTER 5: CONCLUSION 
 
5.1 Discussion. 
The results of this study were largely in line with what was anticipated. 
Due to the lack of previous studies in the literature on the associations between pro-
inflammatory diet and chronic pain, no comparison could be made between this 
study’s results and others. Nonetheless, a discussion about these results and their 
quality, impact and applicability can be found in this chapter. 
 
5.1.1 Baseline characteristics 
The baseline characteristics analysis of the population sample highlights 
some of the major limitations of the current study.  
A number of differences were found at baseline for the population >20 
years of age (included versus excluded population). Significant differences were 
found in gender, level of education, level of physical activity performed each day, 
marital status, race/ethnicity, number of people per household, insurance coverage, 
annual income, and BMI. These differences made the occurrence of chronic pain 
more likely within the observed population, therefore limiting the generalizability of 
the results. Non-significant differences were found for the variables of diagnosis of 
diabetes, general health conditions and age. 
The limitations of the internal validity are highlighted by the numerous 
differences at baseline for the study population (individuals with chronic pain versus 
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excluded population). Significant differences were found in gender, level of 
education, level of physical activity performed each day, diagnosis of diabetes, 
race/ethnicity, annual income, and BMI. These confounders have an impact on both 
diet and chronic pain, and their unbalanced presence in this study population have an 
unpredictable effect. To reduce this effect, all the significantly different confounders 
from the univariate analysis were adjusted for in the multivariate analysis. All the 
significant variables in the multivariate analysis were then considered for the selection 
method used to build the final model. 
 
5.1.2 DII and CP in LB and neck  
The univariate analysis performed on the association between DII and 
relevant covariates and chronic pain presence showed interesting results. DII levels 
have been found to be significantly associated with the presence of chronic pain in the 
univariate analysis with a p-value of 0.0099. This p-value is not highly significant, but 
when examining the OR (1.036) for different levels of DII values (as shown in 
chapter 4, section 4.2.1), it is clear that a large difference in DII can have a significant 
impact in the presence of chronic pain.  
Although not quite applicable to any real life situation, two diets at the 
opposite extremes of the DII spectrum would have a highly significant difference in 
odds (OR=1.7676). These data exemplify the difference that a completely anti-
inflammatory diet could have when compared to a fully pro-inflammatory diet. In this 
extreme example, an individual with a highly pro-inflammatory diet increases the 
chances of having chronic pain in the lower back or neck by 76.76%, when compared 
to someone having a completely anti-inflammatory diet. The interpretation of this 
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result sheds light on the potential importance of diet in relation to chronic pain in 
lower back and cervical spine. However, these statistics have limited applicability due 
to the fact that the univariate analysis does not account for confounding effects. 
Multivariate analysis of the effect of DII on chronic pain presence showed 
a loss of significance of the DII itself, when gender, education level, level of physical 
activity, diagnosis of diabetes, race/ethnicity, general health condition, annual income 
and BMI were adjusted for in the analysis. Education level, diagnosis of diabetes, and 
BMI lost significance as well, yet these three factors became strongly non-significant, 
while DII became non-significant with a p-value of 0.0610. In this analysis, DII, 
although not significant anymore, may still may have some relevance in the 
construction of the final model, for it still shows an OR that is pointing towards a 
positive association (OR= 1.028, 95%CI= 0.999 – 1.059). The loss of significance has 
different possible interpretations, and it may be that the flaws of the population’s 
baseline characteristics taken into account play a role in it. Confounders’ distribution 
may play a significant role in determining the overall effect of the main variable, 
although it is not possible to draw definite conclusions. It may also be that DII does 
not have an actual association with the presence of long term pain in lower back and 
neck. 
To make sure that the best model fit all the relevant variables, a stepwise 
selection method was run with all the factors found to be significant at a p-value of 
0.20. The stepwise selection method analysis found that, considering all the 
significant variables in this analysis, only gender, general health condition, annual 
income and DII were significant and relevant for the best fitted final model 
construction. 
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When a multivariate analysis of the DII effect on chronic pain presence 
was run again including only the variables found significant in the stepwise selection 
method, the DII retained significance (p= 0.0346), although it was diminished 
compared to the initially discovered value found in the univariate analysis. The lack 
of interaction between the variables included in the final model increases the strength 
of the results found. 
When considering this specific population and confounders, DII has a 
significant, albeit weak, effect on chronic pain in the neck and lower back. This result 
illustrates the importance of the effect that diet-related inflammation may have on 
chronic pain. There is a need for more studies in this area to investigate the effect of 
anti-inflammatory diet on the presence of chronic pain. If results are consistent in 
future studies, the possibility of an anti-inflammatory diet as a treatment approach 
should be further investigated as well.  
 
5.1.3 DII and pain > 24 hours 
The univariate analysis of covariates and DII effect on pain lasting more 
than 24 hours in the month prior to the interview also showed significant and 
interesting results. In this univariate analysis, gender, diagnosis of diabetes, marital 
status, race/ethnicity, general health condition, annual income, BMI, and DII were all 
found to be significantly associated with pain lasting more than 24 hours. In contrast, 
education level, level of physical activity, number of people per household, insurance 
cover, and age were not found to be significantly associated with the outcome 
variable. In this case, DII had a very strong significance, with a p-value= <.0001, 
OR= 1.073, and 95%CI= 1.042 - 1.106. This result points to the possibility that 
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inflammation may be an important predisposing factor for chronic pain. If individuals 
with higher diet-related inflammation levels are more likely to have pain for longer 
than 24 hours, then it is possible that this inflammation plays a role as one of the early 
predisposing factors for the development of chronic pain. 
The multivariate analysis of the effect that DI has on pain lasting more 
than 24 hours in the preceding month was also performed with all the significant 
covariates accounted for in the model. The DII retained its significance and neither its 
p-value, nor its OR changed. Diabetes and BMI lost their significance, although with 
a p-value lower than 0.2, and were therefore included in the stepwise selection 
method. The selection method confirmed that both factors were non-significant in this 
model, together with age, while all of other confounders proved significant.  The DII 
maintained its significance and its OR increased to 1.079 (95%CI of 1.044 to 1.115) 
when non-significant variables were taken out of the final model. No interactions 
were found to be significant between the variables included in the final model. 
A strong association is therefore evidenced between DII levels and pain 
lasting longer than 24 hours. This association made the further analysis of pain 
duration more relevant. 
 
5.1.4 DII and pain duration 
The last analysis performed for this study involved the univariate analysis 
of DII and relevant covariates on pain duration, dichotomized as pain less than three 
months and pain longer than three months. An analysis of each of the variables found 
education level, level of physical activity, race/ethnicity, number of people per 
household, general health condition, annual income, age, and DII to be all 
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significantly associated with pain lasting more than three months. Gender, diagnosis 
of diabetes, marital status, insurance cover, and BMI were all found to be non-
significantly associated with the outcome variable. In this case, DII was significant, 
with a p-value= 0. 0.0164, OR= 1.012, and 95%CI= 1.042 to 1.106. 
Multivariate analysis of the DII’s effect on pain duration was then 
performed with all significant covariates accounted for in the model. DII lost its 
significance with a p-value= 0.2956 and an OR= 1.033 and 95%CI= (0.972 - 1.099). 
This significance-value was above the threshold of the p= 0.20 that was applied for 
the other stepwise analyses. For this reason, the stepwise calculation method was not 
performed for this model. Lack of control for the confounders might have played a 
prominent role in the loss of significance found in the univariate analysis. Considering 
the weaknesses of this study, as well as the significant level found in the univariate 
analysis, it is reasonable that a better study design would yield more conclusive 
results. Therefore, further investigations on this topic are needed. 
Nonetheless, from these results it seems that diet-related inflammation 
levels might be minimally involved with a duration of pain longer than three months. 
 
5.1.5 Interpreting the DII 
To interpret the results from this study, it is important to have an 
understanding of how to match DII scores to specific diets. A variety of factors play a 
role in the final DII score, and it is therefore important to understand these factors and 
how they are related to different foods and diets. When considering the 45 items used 
for the calculation of the DII, only 9 items have pro-inflammatory effects, while the 
remaining 36 have a protective effect towards inflammation. It is therefore important 
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to understand why the majority of people assessed in this study tended towards a pro-
inflammatory diet. 
First, the quantities consumed of each of these food components must be 
considered. While the number of food items that are anti-inflammatory is higher than 
the pro-inflammatory ones, pro-inflammatory food components are mainly 
macronutrients (e.g., carbohydrate, total fat, cholesterol, protein, saturated fats, trans 
fats and total energy intake calculated in kcal). For this reason, they are consumed in 
much higher quantities than the anti-inflammatory food components, which are 
mainly micronutrients (e.g., vitamins, oligo minerals, flavonoids), spices (e.g., garlic, 
ginger, saffron, turmeric, pepper, thyme and rosemary), higher-quality fats (e.g., 
MUFA, PUFA, n-3 fatty acids, and n-6 fatty acids), and dietary fibers. These food 
components are mostly present in items that do not play a major role in the typical 
diet adopted in most western countries. Keeping in mind that the calculation of DII 
score depends on the inflammatory effect score applied to the effective quantities of 
food eaten, higher quantities of foods consumed will have a stronger effect on the 
final score calculation. 
Second, the way that combinations of foods in different diets impact the 
final DII score must be considered. In order to understand how different diets impact 
the DII, it is important to understand how the 45 food components are represented in 
foods of general consumptions. In order to give real-life examples, two typical dietary 
patterns (described in chapter 3) are analyzed: the “Western dietary pattern” (WDP), 
which has been associated with a pro-inflammatory effect, and the “prudent dietary 
pattern” (PDP) which has been associated with an anti-inflammatory effect.  
 84 
In the WDP, there is a preponderance in the consumption of meats (both 
red and processed), butter and other high-fat dairy products, eggs, white potatoes, 
refined grains, high-sugar drinks and processed food containing elevated quantities of 
refined sugars and hydrogenated oils. This diet is severely skewed towards the 
consumption of pro-inflammatory food components, such as carbohydrates and total 
energy intake (due to the elevated amounts of refined sugars as well as refined 
grains), proteins, cholesterol, and total fat intake (due to the elevated amounts of 
animal products such as meats dairies and eggs), and higher trans fats intake (due to 
the elevated amounts of processed foods)
[294]
. On the other hand, in the PDP, the 
consumption of most of the anti-inflammatory items is heightened as a result of the 
increased consumption of fruits and vegetables (major source of vitamins, flavonoids 
and oligo minerals), mono-unsaturated fat sources (such as olive oil), poly-
unsaturated fat sources (e.g. nuts and fish), and whole grains (important source of 
dietary fibers). The lower consumption of processed food leaves more space for 
cooking, which usually involves a higher use of spices and herbs. Additionally, a diet 
that has a higher proportion of fruits and vegetables consumption in contrast to higher 
consumption of meats, refined sugars and processed foods typically results in lower 
overall caloric intake, which is relevant for the DII calculation as well. 
 
5.1.6 Overall considerations  
The results from this study highlight the association of diet-related 
inflammation (analyzed through the calculation of the DII score) with chronic pain. 
The overall conclusions drawn from these analyses open up a promising perspective 
for a better understanding of chronic pain mechanisms. It is already widely known 
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that chronic pain is multifactorial 
[295-297]
. It appears from the results of this study that 
diet-related inflammation may be considered as one of these contributing factors. 
Specifically, the data point towards an association between DII levels and presence of 
chronic pain in the neck and lower back, as well as towards a very strong association 
between DII levels and pain lasting more than 24 hours. It appears, therefore, that DII 
levels might be participating in the process of predisposing for chronic pain, by 
making the recovery from the initial pain longer. It also seems that DII levels might 
be a relevant factor involved in determining the length of pain; however, it may not be 
the main factor, as DII scores showed a weak association with pain lasting longer than 
three months. This association points to a possible direct link between DII levels and 
chronic pain, which should be further investigated. 
No other studies could be found that addressed the association between 
diet-related inflammation (measured with DII) and presence of chronic pain, and 
promising results have been highlighted. There is a need for further studies in this 
area with a more sensible study design. These further studies should be tailored to the 
specific characteristics of the chronic pain population. For example, there have been 
studies that showed the importance of sub-classification in the treatment of both sub-
acute and chronic pain population 
[298, 299]
. The ability to provide a specific therapeutic 
approach for different sub-groups within the chronic pain population has proven to 
heighten response to treatment. Therefore, it should be kept in mind that the chronic 
pain population can have very different combinations of contributing factors to the 
origin and perpetration of pain. Diet-related inflammation may be more relevant to a 
specific sub-group within the general chronic pain population than other, less affected 
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sub-groups. Sub-classification should be considered when designing or analyzing the 
results of studies on chronic pain. 
 
5.2 Limitations 
The dataset used was the only one found that included all the data 
necessary for calculating DII and the data regarding non-arthritic and idiopathic pain. 
Since the dataset is from 2003-2004, it might not be a valid representation of the 
current US population (in 2017). Additionally, generalizing the conclusions to any 
other country may be of limited value. Nonetheless, the large number of individuals 
included in the study counterbalances, at least in part, this limitation. 
 
A second limitation is that both the internal and external validity were 
decreased in this study, making the overall generalizability of the results fairly weak. 
A large dataset was used, meant that the results could be potentially significant and 
relevant. However, when considering the results of the Pearson’s 2 test and t-test 
for baseline characteristics though, many differences were highlighted at baseline. 
Differences were found for both the target population and the study population.  
The analysis of the baseline characteristics of the included population 
versus the excluded (> 20yrs old) highlights a limited generalizability (external 
validity) of the study results. Among the 12 known confounding factors for chronic 
pain populations analyzed, eight were found to be significantly different in this study.  
Another limitation of this study arises from the results of the analysis of 
baseline characteristics of the study population (included population: chronic pain vs. 
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non-chronic pain presence). When comparing baseline characteristics of individuals 
with chronic pain versus individuals without chronic pain, significant differences 
were found. Among the 12 known confounding factors for chronic pain populations 
that were analyzed, eight were found to be significantly different in this study. These 
differences highlight limited internal validity for the study results. The chronic pain 
population had a higher percentage of female, a higher percentage of high school 
diploma or more than high school diploma, a higher percentage of people doing very 
little physical activity or heavy duty jobs, a higher percentage of diagnosed diabetes, a 
higher percentage of self-reported good, fair, and poor health status (versus excellent 
and very good status), a higher incidence of income under 45,000USD/year and a 
higher, although minimally so, BMI. These results are consistent with the cofounders 
associated with chronic pain that could be found in current literature. On the other 
hand, in regards to the race/ethnicity significant differences, the population with 
chronic pain shows a higher percentage of non-Hispanic whites and African-
Americans, which goes against the current evidence of being white as having a 
protective effect towards chronic pain 
[274, 300]
. The mechanisms behind this difference 
in perceiving the pain experience are yet to be understood 
[301]
. 
Having these eight above-mentioned confounders balanced between the 
two groups (chronic pain vs. non-chronic pain presence) would have made the results 
of this study stronger and more generalizable. These confounders were adjusted for in 
the multivariate model, which helped increase the internal validity, but questions can 
still be raised about its strength. Further studies involving dietary changes in a chronic 
pain population should aim at reducing the presence of confounders in the study 
population. 
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The third main weakness of this study is that the information about pain, 
although still applicable to the physiotherapy field, could have been defined more 
clearly. This is especially true for the main variable definition, which is lacking a 
clear description of the amount of time that an individual experienced pain for during 
the three months preceding the study. The definition of pain in the relevant questions 
regarding lower back and neck is “pain that lasted a whole day or more”. It is 
specified that only major pains were to be reported, disregarding any “aches and pains 
that were fleeting or minor”. The definition used leaves the possibility of 
misinterpretation by patients and decreases the strength of the results. 
Furthermore, the data collected does not follow the most updated 
definition of chronic pain (which was updated in 2012). This would need to be 
addressed in future data collection for improving generalizability and relevance to the 
pain medicine field. Moreover, relevant information for the pain medication used by 
patients is lacking and should be considered for further investigations. Other data 
points that should be collected include pain levels, pain impact on physical function, 
and ADL (activity of daily living) level.  
A fourth limitation is that the dietary information was collected solely 
from the 24-hour recall questionnaire. Even though the questionnaire has been 
validated and is a reliable tool for data collection of dietary consumption, it has 
limitations in detecting the full spectrum of variability of an individual’s food 
consumption. The data collection comes from a patient’s recall, which is always 
subject to biases, and the recall period is limited to the 24 hours prior to questionnaire 
completion. The fact that the variables used in this study for conducting the analysis 
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were averaged between two days’ random collection of such data helps with reducing 
this problem, but does not solve it. A dataset with a wider time range for collecting 
dietary information could be used in future studies (e.g., the Food Frequency 
Questionnaire). 
Lastly, considering only DII and a limited set of covariates and 
confounding variables in relation to chronic pain is a limitation as well. Many other 
factors may be involved in the experience of chronic pain that were outside the scope 
of this study or could not be assessed using this dataset. 
 
5.3 Implications 
5.3.1 Diet and pain 
Both diet and pain are major components of human life, and yet the 
current evidence on the interaction between them is still lacking. In many cases, there 
is not enough information to support evidenced-based decisions in regards to which 
diet would better suit an individual’s needs. Researchers are starting to look at the 
relationships between diet and chronic conditions with increasing attention and with a 
broader approach. Already, many chronic illnesses (the majority of conditions 
affecting our society) have been associated with specific dietary patterns or 
consumption of specific foods, according to Vos et al.
[302]
. It is suggested from this 
study that chronic pain, being a systemic condition mediated by different pathways in 
the body, could also be mediated by inflammation. 
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5.3.2 Diet assessment as an outcome predictor tool 
Another potential implication involves the development of a specific diet-
related inflammation questionnaire about dietary habits. This questionnaire could be 
used during the intake of chronic pain patients, as well as during the intake of new 
acute patients to possibly predict the development of chronic pain. The development 
of such a questionnaire is a challenge, as multiple factors need to be taken into 
consideration. Dietary assessments present challenges coming from individual 
changes in diet, variability of the food consumed, and presence of processed foods 
(which usually have complex ingredients lists). 
There is a need for research addressing the relationship between chronic 
pain and dietary pattern to define and investigate the relevant clinical sub-groups so 
that they could be properly addressed. 
 
5.3.3 Diet change as possible pain treatment 
Pain mechanisms underlying chronicity are complex, just as much as diet 
effects on the human body are. Therefore, the association found between these two 
factors helps with the understanding of both. The present study points at a new 
possible approach to the multi-dimensional understanding of the chronicity of pain.  
The implications of this understanding extend into possible future ways of 
treating CP. For example, a new approach could involve referring these patients to a 
professional dietician. This professional can address the dietary issues by adjusting 
the patient’s diet and reduce the systemic inflammatory effects mediated by the 
patient’s current food intake. 
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5.4 Conclusion 
This study examined the association between diet-related inflammation, 
measured with DII, and the presence of neck and lower back pain in the three months 
before the interview. Presence of pain for at least three months falls into the definition 
of chronic pain, a highly prevalent condition in the general population of Western 
countries, which results in high direct and indirect costs. The presence of pain in neck 
and lower back was found to be associated with DII levels. More specifically, higher 
levels of DII, a result of a pro-inflammatory diet, were associated with higher odds of 
pain presence in neck and lower back. 
The study also analyzed the levels of DII in relation to pain lasting for 
longer than 24 hours. This step was taken to further understand the time dependent 
association between DII and CP. Presence of pain for a period longer than 24 hours 
was found to be significantly associated with DII levels. More specifically, higher 
levels of DII were associated with higher odds of pain presence for a period lasting 
longer than 24 hours. 
People who self-reported having pain for longer than 24 hours were then 
asked the duration they had pain for, which was the third variable studied. Those 
individuals were screened by analyzing the association between DII levels and pain 
duration. This variable was dichotomized as pain lasting less than three months and 
pain lasting longer than three months. Although the latter analysis (dichotomized pain 
duration) was performed on a smaller population (n= 1033) compared to the 
population (n= 3966) analyzed for the main variable and the secondary variable, it 
still provided interesting results. Pain lasting longer than 24 hours, as well as pain 
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lasting longer than three months, was found to be associated with higher levels of DII. 
While the former showed a strong significance level that retained its significance in 
the final model, the latter showed a weaker significant association which lost its 
significance in the multivariate analysis. The results show that the DII levels do not 
have a significant association with pain duration when this variable is dichotomized 
with a three-month cut-off point. It may be that the loss in significance could be 
related to a different size of population taken into account for the statistical analysis, 
as well as to the difference in baseline characteristics for that population. Further 
studies may help understand further. 
Overall, this study provided interesting results in addressing the research 
question on diet-related inflammation associated with chronic pain. Furthermore, it 
appears that the level of diet-related inflammation calculated with the DII plays a role 
in the etiology mechanism of chronic pain and possibly in its perpetration. More 
research is required in this area to better understand the involved mechanisms. 
 
5.5 Ethical considerations. 
According to the current literature, no risks were anticipated nor foreseen 
in regards of physical, emotional or psychosocial harm. Datasets do not contain any 
identifiers. The HREA, the ethics committee board for the province of Newfoundland 
and Labrador, cleared the study from the need of seeking ethics approval. The dataset 
was downloaded from the CDC website 
[68]
 and kept on the PI’s computer. 
According to the definition of the study population, no participants 
requiring additional consideration were included. Considering the use of secondary 
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data, which does not involve any intervention and does not anticipate any risk, there 
was no need for any special consideration, other than the ones already considered. 
At the time of data collection from the NHANES, ethics approval was 
sought from the NCHS Research Ethics Review Board (ERB) and granted. Consent 
was obtained from each participant, in the case of interview only, or twice in the event 
of both an interview and examination. 
No conflicts of interest are present.       
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